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This thesis was submitted in partial fulfilment of the requirements of the degree of 
Doctor in Clinical Psychology at the University of Birmingham. It comprises two volumes. 
Volume I consists of the research component of the degree, Volume II of the clinical 
component. 
Volume I is concerned with the effects of psychotherapy on the human brain. It 
contains a literature review, a research paper and a public dissemination document. The 
literature review is a critical evaluation of brain imaging studies that attempted to identify 
how neural processing changes in patients after having received cognitive behavioural 
therapy for an anxiety disorder. The research paper reports the finding of a randomised 
controlled trial that investigated how the brain’s threat processing mechanisms changed 
after patients received cognitive behavioural therapy for their panic disorder. The public 
dissemination document contains a brief summary of the work written in a style that is 
(hopefully) accessible and (at least somewhat) informative to non-expert audiences. 
Volume II contains five clinical practice reports (CPRs). CPR1 is a case 
formulation of a gentleman with obsessive-compulsive symptoms. Two conceptually 
different formulations of his presentation are presented. One is based on cognitive-
behavioural principles, the other is formulated within a psychodynamic framework. CPR2 
is a single-case experimental design that attempted to evaluate whether CBT led to a 
statistically robust improvement for a lady with panic disorder. CPR3 presents a case study 
of an ex-military serviceman who received CBT for posttraumatic stress disorder with a 
particular focus on the technique of nightmare rescripting. CPR4 reports the findings of an 
evaluation of a provider of neurorehabilitation service s against how well it adhered to 
national guidelines on screening and interventions for depression. CPR5 was an oral 
 
 
presentation of the case of a fourteen-year-old girl who received CBT for obsessive-
compulsive disorder. Its abstract is reproduced in the present volume. 
Names, initials and other identifiers of patients and service settings were altered in 
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A Critical Review of Functional Brain Imaging Studies on the Neural Effects of 
Cognitive Behavioural Therapy in Anxiety Disorders 
  




Background: Cognitive behavioural therapy (CBT) is the first line treatment for anxiety 
disorders recommended by clinical guidelines. However, little is known about how CBT 
works at a neural level. Aim: To critically review functional magnetic resonance studies of 
the neural effects of CBT for anxiety disorders. Method: A systematic search of the major 
scientific literature databases identified thirteen studies of relevance. Results: The anxiety 
disorders studied were spider phobia, social phobia, posttraumatic stress disorder and panic 
disorder. CBT was shown to be effective in reducing symptoms in all studies. All studies 
identified neural activation changes in brain regions located within the brain's fear 
processing network. Specific findings were variable, however, and no consistent neural 
response signature was found across or within disorder categories. The highest degree of 
agreement existed about the amygdala, insula and anterior cingulate cortex: When their 
activation changed as a function of CBT it was typically reduced after treatment. 
Conclusions: Agreement exists that CBT for anxiety results in changed neural processing 
of threat related information. This is an emerging field of research, however, and 
significant methodological shortcomings will need to be overcome in the future in order to 
obtain more consistent findings that will prove reliable, replicable and robustly 
interpretable. 
  




Anxiety disorders are amongst the most prevalent mental health difficulties across 
cultures and societies. (Baxter et al., 2013; Kessler et al., 2005). They frequently take a 
chronic course and, as a consequence, have a significant impact on sufferers’ quality of life 
(Rapaport et al., 2005). The cost of interventions and loss in productivity presents a 
substantial socioeconomic burden (Whiteford et al., 2013).  
Cognitive behavioural therapy (CBT) is the first line treatment recommended by 
clinical guidelines for a range of conditions across the spectrum of anxiety disorders 
(NICE, 2005a, 2005b, 2011, 2013). Whilst the majority of recipients of CBT show some 
clinical improvement, a considerable number of patients responds only with partial 
symptom resolution (Barlow et al., 2004) and relapse rates remain high (Cuijpers et al., 
2013; Roth et al., 2006), particularly in the longer term (Durham et al., 2005). 
Based on the work by DeRubeis & Feeley (1990) and Jacobson et al. (1996) numerous 
authors have argued for the empirical identification of the specific active components 
within CBT to determine the most effective treatment ingredients (Ahn & Wampold, 2001; 
DeRubeis et al., 2005; Marks, 2002; Wampold, 2005). Such efforts have only had some 
success. So-called nonspecific factors, such as the therapeutic alliance, often explain more 
outcome variance than specific therapeutic ingredients (Chatoor et al., 1979). The 
possibility needs to be considered that individual patient characteristics or an interaction of 
patient factors, therapist attributes and therapy ingredients may be more predictive of 
therapeutic change.  
Given the large body of neuroanatomical evidence on the aetiology and 
maintenance of fear and anxiety (Bishop, 2007; Britton et al., 2011; Delgado et al., 2006; 
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Kim et al., 2011; Ray & Zald, 2012) the study of the neural correlates of effective therapy 
may hold promise. A better understanding of the neurocognitive mediators of effective 
psychotherapy could be instrumental in allowing us to refine treatments better. Reliable 
probes of these may ultimately serve as biomarkers to aid the evidence based selection of 
personalised medical, psychological and integrated treatment pathways (Cortese, 2007; 
Hamburg & Collins, 2010; Lesko, 2007).  
Of all the neural imaging methods functional magnetic resonance imaging (fMRI) 
is the most promising for this purpose. It measures a physiological marker of regional 
blood flow, a correlate of neural transmission (Logothetis, 2002, 2003; Logothetis & 
Wandell, 2004) noninvasively and without the use of ionising radiation. Its comparatively 
high spatial and temporal resolution, widespread availability, relative ease of 
administration and good safety record position it uniquely within the mix of neuroscience 
methods (Walsh & Cowey, 2000). Since its conception in the early 1990s it has therefore 
become the most successful human brain mapping tool (Raichle, 2009). 
This review provides a systematic overview of all studies published to date that 
have used fMRI to identify the neural correlates of symptom improvement as a function of 
CBT for anxiety disorders. Whilst several articles have been published that summarise 
functional imaging investigations of psychotherapy (Linden, 2006; Messina et al., 2013; 
Porto et al., 2009; Roffman et al., 2005) the present review is novel in that it focuses on 
fMRI, anxiety disorders and CBT alone. Its aims are, firstly, to describe the neural changes 
associated with CBT for anxiety, secondly, to highlight methodological limitations in the 
published research and, thirdly, to identify research questions that in the future may be 
helpful in furthering our understanding of how exactly effective psychotherapy works at a 
neural level and whether such knowledge may be helpful in devising treatments, or 
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selecting therapeutic treatment ingredients, that may increase efficacy and reduce non-
response and relapse.  
  





The remit of this paper is to review English language publications of experiments 
and randomised controlled trials that quantify the effect of CBT for anxiety disorders on 
neural markers in adults. To identify these, a search of the databases Embase, Medline and 
PsycINFO was conducted. The search strategy combined semantic permutations of the 
concepts “fMRI”, “CBT” and “anxiety disorders”. The latter was defined to include those 
mental disorders which have been shown to be treatable effectively with CBT, i.e. specific 
phobias, panic disorder, social phobia, generalised anxiety disorder (GAD), 
hypochondriasis and posttraumatic stress disorder (PTSD) (Clark & Beck, 2011; Wells, 
2013). In the prevailing diagnostic system, DSM–5, these generally overlap with the 
definition of anxiety disorders (American Psychiatric Association, 2013). An exception is 
PTSD. Even though since last year it has been comprised in a separate category of 
disorders it nevertheless shares much of its hypothesised neurobiological underpinnings 
with the remainder of the anxiety disorders (Shvil, Rusch, Sullivan, & Neria, 2013). In the 
new edition of DSM, obsessive-compulsive disorder (OCD) is also no longer comprised 
within the anxiety disorders. Whilst this has sparked considerable debate (Bystritsky et al., 
2013; Nemeroff et al., 2013; Stein et al., 2010) its neurobiology is indeed very distinct 
from the anxiety disorders and positions it much closer to tic and movement disorders 
(Bartz & Hollander, 2006; Münchau et al., 2002). OCD will therefore not form part of this 
review. 
The database search strategy is presented in Table 1. The literature search was 
conducted on April 15th, 2014 and limited to papers published since 1987, prior to the 
conception of fMRI. It yielded 319 results.  
fMRI Studies of CBT in Anxiety Disorders: A Critical Review 
7 
 
Table 1. Search strategy used to interrogate the databases Embase, Medline and PsycINFO 
for original studies researching the neural effects of cognitive-behavioural therapy in 
anxiety disorders using functional magnetic resonance imaging. 
Query  Search term Hits Query Search term Hits 
#1 functional 1777236 #18 anxiety 449207 
#2 magnetic 1394266 #19 phobia 29663 
#3 resonance 1423027 #20 phobic 16553 
#4 imaging 1624660 #21 panic 44822 
#5 #1 and #2 and #3 and #4 137677 #22 social 1516189 
#6 fmri 68554 #23 #18 and #22 90070 
#7 #5 or #6 150261 #24 #19 or #20 39581 
#8 cognitive 783323 #25 #22 and #24 20803 
#9 behaviour 324813 #26 #24 or #25 39581 
#10 behavior 2050799 #27 posttraumatic 93990 
#11 behavioural 134300 #28 stress 1340050 
#12 behavioral 574966 #29 #27 and #28 71447 
#13 #9 or #10 or #11 or #12 2592774 #30 health 4430838 
#14 therapy 3993705 #31 #18 and #30 108771 
#15 psychotherapy 202440 #32 hypochondriasis 6565 
#16 #14 or #15 4101391 #33 #31 or #32 114396 
#17 #8 and #13 and #16 82336 #34 #18 or #19 or #20 or #26 or 
#29 or #33 
550934 
   #35 #7 and #17 and #34 319 
 
Inclusion Criteria 
For a search result to be included in the final literature review it had to fulfil the 
following inclusion criteria: It needed to be an original research report published in 
English in a peer reviewed journal reporting experimental research using fMRI to identify 
the neural effects of CBT in an adult study population. After removal of duplicates (72 
exclusions), non-English articles (14 exclusions), review articles (85 exclusions), 
conference abstracts (52 exclusions), books (2 exclusions) and editorials (5 exclusions) 89 
articles of possible interest remained. Abstracts were read to eliminate 74 articles which 
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either did not report research on CBT for anxiety or were using paediatric populations. 
Three studies (Bryant et al., 2008; Doehrmann et al., 2013; Falconer et al., 2013) were 
excluded because they used fMRI solely to predict subjects’ responses to CBT without a 
post-therapy brain scan to examine the correlates of therapeutic change. Perusal of the 
references cited in the remaining twelve papers revealed one more article of interest 
(Hauner, Mineka, Voss, & Paller, 2012), giving a total of thirteen studies as target for the 
present review. Figure 1 shows a flowchart of inclusion and elimination of research reports 
for the present review. 
fMRI Studies of CBT in Anxiety Disorders: A Critical Review
 










Articles were classified according to the specific anxiety disorder of interest and, 
within these, are reviewed in order of their date of publication. Functional imaging 
findings of post- versus pre-therapy brain scans were extracted and evaluated in light of 
the experimental design and control procedures applied, sample sizes, suitability of the 
functional neural activation paradigms employed, consistency with a priori hypotheses and 
the plausibility of the authors’ integration of their results with the relevant background 
literature  
Quality Criteria 
Even though all of the reviewed articles employed a cognitive-behavioural 
intervention to reduce anxiety, they did so in order to study whether and how neural 
processes change as a function of successful therapy. This contrasts with studies that aim 
to assess the efficacy of healthcare interventions. Only the latter type intends to evaluate 
whether a clinical intervention works or whether its efficacy is better than that of other 
known interventions. It is this type of study that is typically referred to as a “clinical trial” 
and questions of clinical efficacy are most reliably addressed using the methodological 
design of a randomised controlled (clinical) trial (Moher et al., 2010). None of the studies 
reviewed in this chapter attempted to evaluate the clinical efficacy of therapeutic 
interventions for anxiety but studies using interventions to influence neural or other 
systems would also do well to use the methodological principles of experimental control, 
randomisation and blinding to permit unequivocal and unbiased attribution of any 
observations of change to the clinical intervention employed.  
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Quality frameworks such as the CONSORT statement (Schulz et al., 2010) have been 
developed to permit an objective appraisal of the quality with which clinical efficacy trials 
have been designed, conducted and analysed. Even though their principal remit is to 
reduce a biased reporting of clinical efficacy they can also be helpful in ensuring that non-
efficacy trials are reported to a high standard. Whilst some quality criteria do not apply to 
non-efficacy trials the majority of criteria is appropriate because the research philosophies 
underlying the different types of studies share considerable commonalities. For this reason 
the experimental studies included in this review have been appraised against the criteria of 
the CONSORT checklist reproduced in Table 2 below. 
 Using this checklist papers were rated against whether each item had been reported 
adequately as commanded by the guidelines, partially so or not at all. At times certain 
items were identified as not applicable to individual studies (e.g. the requirement for 
identification as randomised trial when no randomisation had taken place or the 
requirements on how binary outcomes should be reported when no such outcomes existed). 
For each paper a CONSORT adherence score was computed by summing the number of 
items adhered to and dividing them by the number of applicable items and expressed as a 
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Table 2. CONSORT (Schulz et al., 2010) checklist items used to appraise the quality of 
the reporting standards in the studies reviewed. 
Section/topic  Item 
no. 
Checklist item 
Title and abstract 1a Identification as a randomised trial in the title 
 1b Structured summary of trial design, methods, results, and conclusions 
Introduction   
Background and 
objectives 
2a Scientific background and explanation of rationale 
2b Specific objectives or hypotheses 
Methods   
Trial design 3a Description of trial design (such as parallel, factorial) including allocation 
ratio 
 3b Important changes to methods after trial commencement (such as 
eligibility criteria), with reasons 
Participants 4a Eligibility criteria for participants 
 4b Settings and locations where the data were collected 
Interventions 5 The interventions for each group with sufficient details to allow 
replication, including how and when they were actually administered 
Outcomes 6a Completely defined pre-specified primary and secondary outcome 
measures, including how and when they were assessed 
 6b Any changes to trial outcomes after the trial commenced, with reasons 
Sample size 7a How sample size was determined 
 7b When applicable, explanation of any interim analyses and stopping 
guidelines 
Randomisation:   
 Sequence 
generation 
8a Method used to generate the random allocation sequence 





9 Mechanism used to implement the random allocation sequence (such as 
sequentially numbered containers), describing any steps taken to conceal 
the sequence until interventions were assigned 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, 
and who assigned participants to interventions 
Blinding 11a If done, who was blinded after assignment to interventions (for example, 
participants, care providers, those assessing outcomes) and how 
 11b If relevant, description of the similarity of interventions 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary 
outcomes 
 12b Methods for additional analyses, such as subgroup analyses and adjusted 
analyses 
Results   
Participant flow  13a For each group, the numbers of participants who were randomly assigned, 
received intended treatment, and were analysed for the primary outcome 
 13b For each group, losses and exclusions after randomisation, together with 
reasons 
Recruitment 14a Dates defining the periods of recruitment and follow-up 
 14b Why the trial ended or was stopped 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each 
group 
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Numbers analysed 16 For each group, number of participants (denominator) included in each 
analysis and whether the analysis was by original assigned groups 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the 
estimated effect size and its precision (such as 95% confidence interval) 
 17b For binary outcomes, presentation of both absolute and relative effect sizes 
is recommended 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and 
adjusted analyses, distinguishing pre-specified from exploratory 
Harms 19 All important harms or unintended effects in each group  
Discussion   
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if 
relevant, multiplicity of analyses 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and 
considering other relevant evidence 
Other information   
Registration 23 Registration number and name of trial registry 
Protocol 24 Where the full trial protocol can be accessed, if available 
Funding 25 Sources of funding and other support (such as supply of drugs), role of 
funders 
   
   
   
   












Table 3. Demographic and methodological design characteristics of the studies reviewed. 
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f, female; m, male; HC, healthy control participants; TG, treatment group; WG wait list group; CBT, 
cognitive-behavioural therapy; ROI, region of interest; PTSD, posttraumatic stress disorder; ABM, attention 
bias modification 
Table 3 shows a description of the sample characteristics and design paranmeters 
of the studies reviewed. Sample sizes ranged between 8 and 94 participants with group 
sizes accordingly smaller. The majority of studies tested participants of both genders 
although some recruited female participants only. Eleven of the thirteen brain imaging 
studies reviewed used a control group or a control condition of some sort and, when 
patient controls were used allocation to groups was always randomised. CBT varied 
widely and was not always described in sufficient details to determine to what extent it 
overlaps with the treatment characteristics recommended in clinical guidelines. The 
therapy paradigms were diverse with respect to the duration of treatment, whether it was 
delivered individually or in groups, face to face or over the Internet. In all bar one (Farrow 
et al., 2005) of the studies therapy incorporated an element of exposure to feared stimuli or 
cognitions. The majority used a form of symptom or threat provocation during subjects’ 
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brain scans. Table 4 contains an overview of the main design characteristics and a 
summary of the key findings of the studies reviewed. 
Table 4. Key changes in neural activation and deactivation response to symptom 
provocation and related challenges as a function of completed psychotherapy. 
Abbreviations and symbols: , increased BOLD activation; , decreased BOLD 
activation; PFC, prefrontal cortex; ACC, anterior cingulate cortex; OFC, orbitofrontal 
cortex; US, unconditioned stimulus. 
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PTSD Empathy judgements of social 
narratives 
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posterior middle temporal gyrus 
Felmingham 
et al. (2007) 
PTSD Briefly presented masked 
fearful facial expressions 
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 When judging the papers against the CONSORT criteria, several of these were 
found to not apply, or to only partially do so. Of the 37 items 4 were judged as applying to 
none of the studies reviewed. These included item 7b (interim analyses and stopping 
guidelines) and item 17 b (reporting of binary outcomes). An additional 10 items only 
applied to some (between 3 and 11) of the studies reviewed: E.g. item 1 (identification as 
randomised trial in the title) was not a fair quality criterion for studies that could not use 
randomisation. 24 items were, however, deemed to be ap[applicable to all studies. Table 5 
shows how the studies fared when rated against the CONSORT criteria.  
 
Table 5. Results of the quality judgement of studies reviewed against the CONSORT 
(Schulz, 2010) guidelines. Items were scored as fully (y), partially (p) or not complied with 
(n). Items marked n/a were deemed not applicable. The quality score in the bottom row 
expresses the percentage of items a study report showed full compliance with, not taking 
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1a n/a n n/a n n/a n n/a n/a n/a n/a y n/a n 
1b n n p n n n y y n n y n n 
2a y y y y y y y y y y y y y 
2b y p p y p p y y y y y y y 
3a y y y y y y y y y y y y y 
3b n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 
4a y y y y y y y y y y y y y 
4b n n n n n n y y n n n n y 
5 y y y y y p y y n p y y y 
6a y y p p y p p y n y y y y 
6b n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 
7a n n n n n n n n n n n n n 
7b n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 
8a n/a n n n n n n/a n/a n/a n/a n n/a y 
8b n/a n n n n n n/a n/a n/a n/a n n/a y 
9 n/a n n n n n n/a n/a n/a n/a n n/a y 
10 n/a n n n n n n/a n/a n/a n/a n n/a p 
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11a n n n n n n n n n n n n n 
11b n/a n/a n/a n/a n/a n/a n n n/a n/a n/a n/a n/a 
12a y y p y p y y y y y y y y 
12b n/a n/a n/a n/a n/a n/a y y n/a n/a n/a n/a n/a 
13a y y y y y y y n y y y y y 
13b n/a y y y y y n/a n n/a n/a n/a n/a y 
14a n n n n n n n n n n n n n 
14b n/a n n n n n n n/a n/a n n n n 
15 n n n y y n y y n n n y y 
16 y y y y y y y n y y y y y 
17a n n n n n n y n n n n n n 
17b n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 
18 n/a n/a n/a n/a n/a n/a y y n/a n/a n/a n/a n/a 
19 n n n n n n n n n n n n n 
20 n y y y y y y y y y y y y 
21 n n n n n n y y y n y y y 
22 y y y y y y y y y p y y y 
23 n n n n n n n y n n y n n 
24 n n n n n n n n n n n n n 
25 y n n y y y y y y y y y y 
% adherence 47.8 36.7 31.0 43.3 41.4 33.3 66.7 63.0 47.8 41.7 55.2 58.3 63.3 
 
General strengths identified by the quality appraisal were that all studies provided 
satisfactory levels of background to justify their scientific rationale (item 2a), described 
their design sufficiently well (item 3a) and report inclusion criteria for their participants 
(item 4a). A generic weakness was, however that none of the studies reviewed provided a 
satisfactory rationale for how the sample size was determined (item 7a), whether and how 
any blinding was implemented (item 11a), when exactly testing took place (item 14a) and 
whether any adverse effects or harms were reported that may have been attributable to an 
intervention (item 19). 
As described above an adherence score was calculated by relating adhered-to items 
to the total number of applicable items for each paper reviewed. Adherence ranged 
between 31% (Goossens et al., 2007) and 66.7% (Kircher et al., 2013), the paper that also 
used the largest sample size. Figure 2 shows the frequency distribution of papers’ 
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adherence to CONSORT reporting standards. The studies with the highest adherence 
scores were thise by Kircher et al. (2013), Månsson et al. (2013) and Lueken et al. (2013). 
Studies with the lowest scores were those by Straube et al. (2006), Hauner et al. (2012) and 
Goossens et al. (2007). The mid-field with adherence scores ranging between 41.4% and 
58.3% was comprised of studies by Klumpp et al. (2013), Goldin et al. (2013), Farrow et al. 
(2005), Paquette et al. (2003), Schienle et al. (2007), Felmingham et al. (2007) and 
Schienle et al. (2009). 
 
Figure 2. Frequency distribution of adherence to CONSORT quality criteria by the 
thirteen reviewed papers. 
Specific Phobia 
To date six studies have used fMRI to investigate the effects of CBT on specific 
phobia. In all of these the fear of interest was a phobia of spiders, presumably due to its 
high prevalence (Boyd et al., 1990; Magee et al., 1996), ease of creating valid symptom 
provocation procedures in the environment of a brain scanner (Johanson et al., 1998) and 
due to the availability of effective and efficient treatment paradigms (Öst, 1989, 1996; 
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The first fMRI study of the neural effects of CBT for arachnophobia was published 
by Paquette et al. (2003). They recruited twelve adult participants who were phobic of 
spiders and were given four weekly group therapy sessions lasting three hours each. 
Functional imaging contrasted neural responses to symptom provocation, using videos of 
spiders, with responses to non-fear inducing videos of butterflies. Patients’ brain 
activations were further compared to those obtained from non-spider phobic control 
subjects.  
Results showed that, before therapy and compared to controls, phobic patients’ 
brains responded to spiders with bilateral activation of the parahippocampal gyrus (BA 36), 
which the authors interpret as an activation of the contextual fear memory system (Bechara 
et al., 1995). Dorsolateral prefrontal cortex (BA 10) showed a right lateralised activation 
which may be a correlate of the patients’ use of volitional cognitive strategies to cope with, 
and reduce, the degree of fear experienced. This fits with the authors’ observation that 
patients attempted to control their fear response by conscious control of their breathing. An 
earlier positron-emission computed tomography study reported a similar result (Johanson 
et al., 1998).  
A third cluster of activation existed in secondary and higher order ventral visual 
processing areas. These are part of the attention network and plausibly reflect the 
deployment of visual attention and (hyper-) vigilance towards the phobic material, 
especially prioritising rapid recognition and identification of threat (Goodale, 2011). 
However, this was a large cluster and the specificity of this effect to subdivision of the 
extrastriate visual system is unclear. This kind of information would be useful to further 
dissect the specific role of neural networks in top-down attention deployment or bottom-up 
visual salience processing (Miller & Buschman, 2013) in future studies. 
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The authors found no activation of the amygdala. This is consistent with earlier 
neuroimaging studies of specific phobias (Fredrikson et al., 1993; Johanson et al., 1998; 
Mountz et al., 1989; Rauch et al., 1995) and may reflect a preferential role of the amygdala 
in the acquisition of a phobia, rather than the maintenance of fear in response to a phobic 
situation (LeDoux, 1993; Rauch et al., 2003). An alternative view is that amygdala 
activation is not seen when scanning phobic subjects because it habituates rapidly to 
repeated or prolonged stimulation with phobic material (Dilger et al., 2003; Straube et al., 
2006). 
CBT was highly effective in this study. After four sessions all patients were able to 
touch a spider without reporting cognitive or physiological symptoms of fear (Paquette et 
al., 2003). The corresponding neural correlates are likely a normalisation of activity levels 
in dorsolateral prefrontal cortex (BA 10) and both parahippocampal gyri (BA 36): after the 
original fear had extinguished, exposure to a previously phobic stimulus no longer required 
the same degree of cognitive effort to cope with this situation. Whilst it may reflect a 
reduced tendency for ‘dysfunctional’ thinking (Beck, 1979) such as cognitive 
misattributions (Gorman et al., 2000), it may also result from the reduced salience of the 
phobic object through extinction and, therefore, a concomitant reduction of vigilance to the 
feared object and efforts to engage in coping or avoidance strategies. 
The main methodological limitation of this paper is that the healthy control 
subjects were only scanned once, whereas the patients were scanned before and after 
therapy. It can thus not be ruled out that the changes seen in patients are not related to CBT 
per se but reflect nonspecific changes, such as habituation to brain scanning procedures, 
which themselves may be more anxiety provoking in subjects with high levels of anxiety 
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(Hunt et al., 2011; Lueken et al., 2011; McGonigle et al., 2000). For the same reason it 
would have been desirable to have an untreated or placebo-treated patient control group. 
Straube et al. (2006) improved on the design of Paquette et al. (2003) by adding a 
group of spider phobic patients who were scanned at the same time points as the treatment 
group but did not receive therapy. This controls for possible nonspecific effects, such as 
habituation to the experimental procedure in the brain scanner, that may have occurred 
concurrently with psychotherapy. Twelve spider phobic patients underwent two sessions of 
group CBT which lasted several hours on consecutive days and was highly effective. 
Thirteen patients were allocated to a waiting-list control group. Treatment group patients 
were scanned at two time points, immediately before psychotherapy and about two weeks 
after. Waiting-list control patients were scanned at identical time intervals but without 
receiving treatment. A third group of healthy control subjects was scanned once only. 
During brain scans participants viewed videos of a spider, which were fear inducing in 
untreated patients. Neural activations in response to these were contrasted with those to 
non-fear inducing control videos. 
The authors found that, prior to therapy, threat processing in patients led to 
elevated activation in the insula and the anterior cingulate cortex (ACC). After therapy 
these responses fell to near normal levels. The insula is a brain region that is involved in 
sensing the body’s homeostatic state and deviations from it. It is closely coupled with the 
autonomic nervous system (Critchley et al., 2001)and has increasingly been linked with 
threat processing and emotional awareness (Grupe & Nitschke, 2013).  
Overactivation in the ACC, in particular its dorsal portion, normalised as a 
consequence of therapy. Like the insula, the dorsal ACC had been linked with sympathetic 
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nervous system arousal (Critchley et al., 2003) and, more recently, has been suggested to 
play a key role in appraisal, regulation and suppression of negative emotion (Etkin et al., 
2011), making it a plausible neural candidate area to exhibit markers of therapy related 
cognitive changes. 
Goossens at al. (2007) expressed their surprise that neither Paquette et al. (Paquette 
et al., 2003) nor Straube et al. (2006) found a change in amygdala activation as a correlate 
of therapy. They speculated that this may have been due to the activation paradigms used. 
Breiter et al. (1996) reported that the amygdala habituated rapidly to visual stimulation. 
Thus the stimulation paradigms in the previous work (presentation of fear-inducing stimuli 
in longer-lasting blocks) may have followed a suboptimal time course. To allow for such 
rapid habituation of amygdala activity, Goossens et al. (2007) used an event-related 
paradigm in which a more rapidly changing time course could be measured relative to the 
presentation of phobic images of spiders compared to control images of snakes. Sixteen 
spider phobic subjects were scanned before and two weeks after a highly effective single 
therapy session based on the approach by Öst (1989). Fourteen healthy control subjects 
were scanned once only. Regions of interest were the amygdala, ACC and insula.  
Compared with controls, phobics had significantly elevated activation of their left 
amygdala when viewing spiders prior to therapy. After CBT this normalised and was no 
different from activations in response to viewing snakes – a pattern exhibited by healthy 
controls. Previously elevated activity in the ACC and the left insula also reduced to control 
levels, in line with the findings by Straube et al. (2006). 
The normalisation of fear-related elevated amygdala responses after CBT is 
congruent with the well recognised role of the amygdala within the fear network (LeDoux, 
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1999). Since the authors scanned their control subjects only once the effects of CBT on the 
observed neural changes cannot be determined with certainty. Whilst a normalisation of 
fear network responses is plausible it is possible that this occurred as a consequence of 
therapy-nonspecific learning and habituation effects. 
Schienle et al. (2007) also noted with interest that none of the first two studies 
identified the amygdala as area of therapy-related change since it is a core structure of the 
fear network (LeDoux, 1999). They thus sought to replicate the study by Straube et al. 
(2006) using a largely identical methodology which included random allocation of 26 
spider phobic patients to a waiting-list or CBT group, pre and post-therapy brain scans for 
all patients and a single scan in a control group of 25 non-phobic volunteers. In addition, 
the authors wanted to investigate the specificity of what appeared to be the neural correlate 
of therapy related changes in processing of previously phobic material in the earlier studies. 
For this purpose patients were scanned during symptom provocation but also whilst 
viewing aversive but non-phobic material.  
Therapy consisted of a single session of group CBT lasting four hours and was 
based on the principles by Öst (1996). It was highly effective in that all previously phobic 
patients could subsequently hold a spider in their hand. Compared to control participants, 
symptom provocation in phobic participants prior to therapy led to increases in activation 
of the amygdala and of visual association cortex. Medial orbitofrontal cortex was less 
activated in patients. The main neural effect of CBT was that orbitofrontal activation 
increased significantly which the authors interpret as consistent with an increased use of 
cognitive strategies, such as restructuring, in order to differently evaluate the valence of 
the – previously phobic – stimulus material. It should be noted that the authors found no 
consistent change in amygdala activation post therapy that reached statistical significance. 
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The authors had a strong a priori hypothesis relating to the effects of their manipulations 
on signal change in the amygdala. It would have been desirable if the authors had 
quantified the effect size they may have expected in order to determine whether sufficient 
statistical power existed to plausibly identify it with the sample size used.  
Six months after their original study the same group performed a further brain scan 
on ten patients of their original therapy group and compared their measures with eight non-
phobic control participants (Schienle et al., 2009). Results showed that the therapeutic 
gains had endured: previously treated participants did not differ statistically from control 
subjects on measures of phobia severity and behavioural avoidance. When contrasting 
brain activations six months after CBT with those obtained prior to therapy, the neural 
correlate of this lasting symptom improvement was a reduced activation of the insular and 
the lateral orbitofrontal cortex and an increase of activity in medial orbitofrontal cortex. 
The authors argue that the orbitofrontal increase is a likely reflection of the patients’ 
enduring cognitive change and propose further that it may reflect a reward signal as the 
patients pride themselves in no longer experiencing fear in response to spiders. It is 
unfortunate that the authors did not report an analysis of how orbitofrontal activation at 
follow-up compared with that immediately post therapy. Inspection of the t-values 
suggests that, had an appropriate repeated-measures comparison been computed, a further 
increase of orbitofrontal activation since the post-therapy scan may well have been 
revealed and it would have been interesting to read the authors’ interpretation, particularly 
within the context of their reward magnitude hypothesis. 
Hauner et al. (2012) published the most recent fMRI investigation of the effects of 
CBT in spider phobia. Twelve spider phobics were randomised to either receive treatment 
or remain on the waiting list. All subjects were scanned at three time points: at baseline, 
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following therapy or a wait of identical duration and six months after. Brain responses to 
phobic stimuli (spiders) and neutral stimuli (moths) were compared.  
At baseline phobics’ brains showed elevated activation in the right amygdala, both 
insular and cingulate cortices. Therapy was highly successful: at the end all patients 
handled a tarantula without significant distress. The corresponding neural changes 
consisted of an increase of activity in, both, the right dorsolateral prefrontal cortex and the 
superior parietal lobule during exposure to spider images. The authors interpret this as 
reflecting the role of the dorsolateral prefrontal cortex in emotional self regulation and 
cognitive reappraisal in line with Herwig et al.’s (2007) suggestion that increased activity 
in prefrontal cortex down regulates fear-related activity in the amygdala. The parietal 
activation was proposed to reflect enhanced visual attention (Goodale, 2011). The 
increased activation at baseline in the amygdala, insula, cingulate as well as ventromedial 
prefrontal cortex all reduced as a function of psychotherapy. 
Six months after therapy the treatment gains were maintained and so were the 
normalised activity levels in all previously elevated regions. Dorsolateral prefrontal cortex, 
however, no longer exhibited the increased activity seen immediately after therapy. The 
authors suggested that when altered behavioural and cognitive strategies were novel, 
cognitive regulation of fear may have played an important role in allowing newly treated 
patients to approach previously phobic material. Emotion regulation of this type has been 
proposed to involve an inhibitory influence by dorsolateral prefrontal cortex over 
amygdala activity (Hartley & Phelps, 2010). As these strategies consolidate and become 
second nature raised prefrontal cortical resources may no longer be required to maintain 
therapy success. 
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In summary, whilst all six studies on specific phobia tested arachnophobic patients 
and all ustilised symptom provocation, the results were varied. The most consistent finding 
concerned the insula: two thirds of the papers reported an activation reduction after therapy. 
Half of the studies found a post-therapy reduction of amygdala activation and half found 
the same in the ACC. Findings on pre- and orbitofrontal cortex were mixed: whilst three 
reports identified CBT related changes in these areas some found increases and others 
decreases in activation leaving a slightly inconsistent picture. 
Panic Disorder 
Two studies have thus far been published that examine the neural response to CBT 
in panic disorder using fMRI. They report data from a large German multicenter 
randomised controlled trial of CBT for panic disorder (Gloster et al., 2009; 2011). Whilst 
both present data from the same functional imaging investigation they attempt to answer 
different questions and accordingly employ different statistical methods. 
Kircher et al. (2013) used a classical conditioning paradigm to investigate the 
neural correlates of patients’ responses to CBT. Large samples of patients and healthy 
controls (each consisting of 42 participants) were scanned whilst learning to associate a 
conditioned stimulus with an unpleasant burst of loud white noise. Patients were scanned 
before and after a six week, twelve session, course of CBT, which was very effective in 
alleviating panic symptoms and agoraphobic avoidance. Controls had their two scans at 
corresponding time intervals. The main finding was that, compared to controls, patients 
exhibited a significantly higher activation in the left inferior frontal gyrus during early 
aversive conditioning trials. This activation had reduced to normal levels when the 
conditioning trials were repeated during the scan after completion of CBT. The authors 
interpret this as showing that CBT reduces patients’ tendency to engage in unhelpful 
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cognitive styles, such as vigilance for threat cues, catastrophising and expectancy of harm 
(Bishop, 2008; Hofmann, 2008). Following CBT, activation related to aversive 
conditioning in patients had also reduced in the amygdala, the ACC, the insula and 
prefrontal areas but these did not reach statistical significance.  
The authors also analysed the functional connectivity of patients’ inferior frontal 
gyrus using the clinical outcomes as covariates. This revealed that, before the 
commencement of CBT, the left inferior frontal gyrus and left amygdala were correlated 
more positively the more agoraphobic patients were. After therapy a larger degree of 
symptomatic improvement corresponded with increased connectivity between patients’ left 
inferior frontal gyrus and bilateral and medial frontal cortex as well as cingulate cortex but 
no longer the amygdala. A reduced need for cognitive regulation of limbic activity could 
arise from reduced bottom-up elicitation of affect rather than increased top-down control. 
The interpretation of the results by Kircher et al. (2013) is compromised because 
no suitable patient control group was included. Any observed differences between pre- and 
posttreatment scans in patients and healthy controls may not solely be due to the effects of 
CBT. It is likely that non-anxious controls habituated differently to a fear conditioning task 
and also to brain scans which themselves are known to be anxiety inducing (Hunt et al., 
2011; Lueken et al., 2011; McGonigle et al., 2000). The current research design confounds 
these aspects and it needs to be considered that the observed effects could solely stem from 
factors not specific to successful psychotherapy of panic disorder. Future work would 
benefit from inclusion of a control group of patients with panic disorder of comparable 
severity who undergo the repeated brain scans and conditioning experiments whilst not 
working on improving their clinical condition. 
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Another criticism relates to the validity of the cognitive-emotional probe used 
during functional MRI scanning. Whilst the authors refer to this paradigm as “fear 
conditioning” (Kircher et al., 2013, p 93), it is unclear how frightened the subjects ended 
up when hearing the conditioned stimulus repeatedly. Whilst it must undeniably have been 
somewhat unpleasant to endure loud bursts of white noise repeatedly, the emotional 
consequences may well have been of quite a different phenomenological quality to the 
dread panic sufferers experience during a panic attack or its build-up during the prodrome 
(American Psychiatric Association, 2013). In support of this view is the original 
publication of the conditioning paradigm used: Its authors stopped short of labelling the 
procedure fear conditioning and only referred to it as “aversive conditioning” (Reinhardt et 
al., 2010, p. 443). A test more closely related to the phenomenology of panic disorder 
would have been one that induces the unprovoked, sudden and intense sense of dread and 
imminent catastrophe that typically accompanies panic attacks. This is of course difficult 
to accomplish in a brain scanner. However, identifying the neural correlates of classical 
conditioning to loud white noise bursts may not further our understanding of the brain 
mechanisms involved in the pathogenesis and maintenance of panic disorder.  
Lueken et al. (2013) presented a different analysis of the functional imaging data 
from the same large trial (Gloster et al., 2011). Of the 42 patients on whom functional 
imaging data were available, 33 were subselected and split into two groups based on the 
degree of symptom reduction they experienced after CBT. Whilst both groups showed a 
statistically significant improvement the authors nevertheless labelled them treatment 
“responders” and “nonresponders”, respectively (Lueken et al., 2013, p. 1346).  
Results showed that the best neural predictor of patients’ non-response to future 
CBT was increased activation in the right ACC, the hippocampus and the amygdala when, 
fMRI Studies of CBT in Anxiety Disorders: A Critical Review 
30 
 
within the classical conditioning paradigm, patients were processing a stimulus that was 
not followed by an unpleasant burst of white noise (i.e., a safety signal). The authors 
suggest that such an elevation of activity in fear-processing structures even when a non-
threatening stimulus is presented may signify a highly hypervigilant attentive state, biasing 
detection towards danger and impairing an ability to discriminate between safety and 
threat.  
The authors’ main remit for this reanalysis of the original dataset was to see 
whether any neural measures could serve as reliable predictors for the outcome of therapy. 
This is a highly relevant question to answer. In order to detect strong relationships between 
variables it is important to maximise their variances as otherwise the covariance, and thus 
correlation, between the two can appear too low (Howell, 2010). The present dataset is 
hampered in that all patients responded to therapy remarkably well. Even the 
‘nonresponders’ showed considerable, and statistically significant, improvement on the 
Clinical Global Impressions Scale (Guy, 1976), the Hamilton Anxiety Rating Scale (Shear 
et al., 2001), the Panic and Agoraphobia Scale (Bandelow, 1995), the Anxiety Sensitivity 
Index (Reiss et al., 1986) and even on the Beck Depression Inventory (Beck et al., 1996). 
In that context it is interesting to note that the neural activation pattern typical for 
treatment nonresponders resolved after CBT which was of course rather successful in 
alleviating at least some of the symptoms. 
The authors appear to have done a substantial amount of statistical transformation 
and analyses in order to identify a neural pattern that predicted treatment response with 
some statistical significance. To put this in perspective, a look at the authors’ data shows 
that the statistically most robust relationship was not between treatment response and a 
neural measure but patients’ baseline score on the Panic and Agoraphobia Scale 
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(Bandelow, 1995) instead. In other words it seems that by far the best predictor of clinical 
outcome remains the severity of patients’ initial presentation: the worse they are the more 
likely they are to leave therapy with residual problems remaining. 
It is worth noting that both the reports by Kircher et al. (2013) and Lueken et al. 
(2013) based their analyses on different number of patients even though they only 
constitute different statistical analyses of the same underlying dataset of the large 
randomised controlled trial by Gloster et al. (2011). Unfortunately no clear rationale for 
this discrepancy was presented. 
In summary, both studies on panic disorder reported the same dataset but focused 
on different statistical analyses. They exhibit a number of methodological inconsistencies 
and different subsamples were selected for inclusion in the two analyses without clear 
rationales for the decisions behind this. The validity of the aversive conditioning paradigm 
for the understanding of aberrant neural processes in the development and maintenance of 
panic disorder is also unclear. The main findings were that, after CBT patients showed less 
recruitment of lateral PFC, presumably because of a lowered tendency to engage in 
unhelpful safety seeking behaviours and maladaptive cognitive strategies such as 
avoidance. Similarly, the more patients recruited neural areas involved in (hyper-) 
vigilance prior to therapy, the less likely they were to benefit from CBT. Unfortunately no 
waiting list control group was included in the design of both papers. Therefore any effects 
seen in treated patients may merely reflect different degrees of adjusting and habituating to 
the scanner environment and experimental procedure, rather than differences brought 
about specifically by CBT. 
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Posttraumatic Stress Disorder 
Two reports have to date been published that aim to identify the neural factors 
involved in CBT for PTSD using fMRI. The first, a paper by Farrow et al. (Farrow et al., 
2005), differs from all other studies reviewed here in that no symptom provocation or 
anxiety induction was studied. Instead the authors use experimental paradigms from the 
field of social cognition and theory of mind. No brain structures within the fear network 
were selected for a region-of-interest analysis. Instead the authors focused on candidate 
areas within the domain of social cognition, based on their previous neuroimaging work in 
a non-clinical population (Farrow et al., 2001). 
Thirteen road traffic accident survivors with PTSD were offered between four and 
ten sessions of CBT which was not further specified apart from that it included a 
“forgiveness component” (Farrow et al., 2005, p. 47). After therapy PTSD symptoms had 
improved significantly. Before and after therapy subjects had an fMRI scan during which 
they read brief social scenarios on which they made judgements regarding the 
forgiveability of actions presented and the degree to which they empathised with them. 
This was contrasted with a social reasoning task.  
Prior to therapy empathy judgements (when compared to social reasoning) led to 
increased activations in right medial frontal and left posterior cingulate gyrus, extending 
into the precuneus. After therapy, left middle temporal gyrus showed increased activations 
during empathy judgements when contrasted with pre-therapy baseline. Forgiveability 
judgements increased baseline activations in left medial frontal and posterior cingulate 
gyrus. After therapy the forgiveability vs. social reasoning contrast revealed increased 
activation in posterior cingulate, medial frontal and left posterior middle temporal gyrus. 
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Unfortunately no data were presented to show how the content of subjects’ social-moral 
judgements changed over the course of forgiveness-based CBT. 
A degree of caution in interpreting the therapy-related findings may be prudent 
because the authors’ results in the narrative of their paper is different from those shown in 
a table. The authors offer the tentative interpretation that their results may demonstrate a 
therapy-related change in semantic processing when making social judgements. However, 
their principal conclusion is merely “that it is feasible to (... measure the effects of 
therapy ...) on the brain’s functional response to cognitive tasks” (Farrow et al., 2005, p. 51) 
– an assumption they must surely already have held when their experiment was in the 
planning stage.  
It is unfortunate that no control subjects – whether healthy or traumatised – were 
included in the design. This precludes the discrimination of therapy-related from 
nonspecific effects, such as the passage of time. Since the authors present no rationale for 
their way of modifying CBT to include a forgiveness component there is no certainty that 
the treatment was evidence based and had proven efficacy. Because no control group was 
tested the clinical changes seen may not only be due to factors separate from therapy but 
could indeed have happened despite of it. 
In their brief paper Felmingham et al. (2007) present an fMRI investigation of eight 
patients who developed PTSD after surviving an accident or interpersonal violence. 
Functional MRI scans were conducted before and after an eight week course of trauma 
focussed CBT. During scans patients viewed blocks of fearful and neutral facial 
expressions that were presented very briefly before being masked. Data analysis centred on 
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the ACC and the amygdala as regions of interest. Therapy was effective and led to 
substantial improvements of PTSD symptoms in all patients. 
The authors found increased bilateral activation of the rostral ACC after therapy 
when viewing fearful facial expressions. They also found two statistically significant and 
strong correlations. Firstly, the degree of activation of the right ACC covaried substantially 
with the degree of symptom improvement after therapy. Secondly, the more fear 
processing related amygdala activation reduced after therapy, the better patients recovered 
from their PTSD symptoms. This is an encouraging finding as the theory base so strongly 
predicts that recovery from an anxiety disorder should also manifest itself in altered threat 
detection and fear processing by the amygdala (Bishop, 2007, 2008; LeDoux, 1999). 
The absence of a control group limits the value of this paper. Any changes the 
authors attribute causally to therapy could also be related to habituation, or any other 
factors that changed during the eight weeks between the baseline and post-therapy brain 
scans. Nor were the authors able to find the therapy related increase of ACC involvement 
in threat processing they had predicted. Given the small sample size this is not entirely 
unexpected and this report should largely be considered a pilot study.  
In summary none of the two papers on PTSD employed a robust design. Farrow et 
al. (2005) had no control group or condition and report insufficient information on their 
test procedure to render their results interpretable within the remit of this review. 
Felmingham et al (2007) tested only eight patients but found that neural activation was 
lower in the amygdala and had increased in the ACC, with both effects corresponding to 
the degree of symptomatic improvement post therapy. 




Three papers exist, all published in 2013, that used fMRI to understand the 
mechanisms of CBT for social anxiety. Goldin et al. (2013) scanned the brains of 60 
patients with social anxiety disorder before and after sixteen sessions of individual CBT. 
During scanning, patients viewed displays of negative self beliefs with individual personal 
relevance. They were instructed to either cognitively reappraise the statements to make the 
belief less upsetting or to react to them by dwelling on the truth value of the statement. 
Activated brain regions were identified using a region of interest analysis.  
The task was successful in significantly affecting negative emotion ratings. 
Therapy was effective in that both reappraise as well as react strategies led to reduced 
negative emotions after CBT than after having waited for treatment. During react trials 
CBT raised activations in the medial prefrontal cortex. During reappraisal CBT was 
associated with increased activity in dorsomedial and left dorsolateral prefrontal cortex. 
No main effects or interactions were found in the amygdala in either of the two tasks. 
However, a functional connectivity analysis in patients after CBT showed an inverse 
relationship between activations of the dorsomedial prefrontal cortex and the left amygdala.  
The authors interpret their results as reflecting more effective frontal cortical top-
down regulation of amygdala based emotional appraisal (e.g., Ochsner & Gross, 2005) 
after successful therapy. It must be stressed, however, that the inverse relationship between 
activation of the amygdala and dorsomedial prefrontal cortex was only obtained when the 
authors selected a seed region in the latter. This location was chosen post hoc, rather than 
hypothesis driven. A more stringent probe of functional amygdala connectivity would have 
been to plant the seed for the analysis there. Nevertheless the authors used the largest 
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sample size of all studies reviewed so far and the use of a wait list control group lends 
good support to its interpretability. 
Klumpp et al. (2013) gave a twelve week course of CBT to fourteen patients with 
social phobia. Before and after therapy patients had an fMRI scan in which presentation of 
happy faces was contrasted with fearful or angry facial expressions. A control group of 
healthy volunteers was also scanned twice using the same paradigm.  
Therapy led to a statistically significant reduction of social phobia in patients. In a 
first step the authors analysed the neural predictors of therapy success. Those patients who 
benefitted most from therapy had greater baseline activation of higher order visual 
processing areas, dorsomedial prefrontal cortex and dorsal ACC in response to threatening 
facial expressions. Increased processing of threatening social stimuli in brain areas 
involved in recognition, evaluation, appraisal and generation of a fear response correlated 
with success of therapy here. 
Analysing the neural correlates of CBT, the authors found that elevated baseline 
activity to angry versus happy faces in dorsomedial prefrontal cortex, middle frontal gyrus 
and insula reduced significantly in patients but not in controls. The authors interpreted this 
as evidence that reduced cognitive biases towards recognition and processing of threat 
signals are associated with enhanced symptom reduction. It should be noted that no 
differential activation of the amygdala was found.  
The interpretability of the results, especially of the latter effects, is jeopardised by 
the lack of a suitable control group. The authors confound being a patient who suffers from 
social phobia with being in receipt of treatment and experiencing symptom improvement. 
Any observed effects could be due to either of those factors. 
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The third paper on social phobia is by Månsson et al. (2013), this time looking at 
CBT delivered via the Internet. 26 patients, of whom 20 provided brain data, were 
randomised to either receive CBT or attention bias modification training as a control 
condition. Internet based CBT consisted of the nine-week therapist guided intervention 
developed by Andersson et al. (2006) which was shown to have good and sustained 
efficacy (Hedman et al., 2011). Attention bias modification is based on the concept that 
cognitive biases, such as the directing of attention towards threat, cause and maintain 
negative affect in anxiety disorders (MacLeod et al., 1986). Reducing such biases, 
typically through computerised tasks using cued visual attention paradigms, has been 
shown to lower the likelihood of experiencing anxiety and its perceived intensity (Clarke 
et al., 2014; Macleod, 2012; MacLeod & Mathews, 2012). The attention bias modification 
group received Internet based training to direct their attention away from disgusted facial 
expressions (Carlbring et al., 2012) twice weekly for four weeks. 
Both CBT and attention bias modification training were effective in lowering 
symptoms of social anxiety although CBT led to a larger improvement. The fMRI 
activation paradigm consisted of a task in which angry, fearful or surprised faces had to be 
processed. At baseline the task induced significant bilateral activation of the amygdala. 
After the treatments this had reduced significantly more in subjects who had received CBT 
compared to those who had attention bias modification. Similar CBT related decreases 
were seen in the cerebellum, somatosensory cortex, basal ganglia and the thalamus. A 
multiple regression analysis was used to further explore the normalisation of left amygdala 
activation in the CBT group. This showed that it was negatively correlated with activity in 
the medial orbitofrontal cortex and positively correlated with that in right ventro- and 
dorsolateral prefrontal cortices.  
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The authors were successful in finding their hypothesized normalisation of anxiety-
related amygdala activation after CBT. This normalisation, together with the associated 
orbitofrontal activation may reflect enhanced top-down control of emotional responses, 
although the authors conceded that the concurrent deactivation of right prefrontal cortex 
was counterintuitive given its role in cognitive control and emotion regulation (Ochsner & 
Gross, 2005). It is, however, congruent with similar findings by Paquette et al. (Paquette et 
al., 2003) and Straube et al. (2006) in spider phobics reviewed above. 
A methodological strength of the current study is the inclusion of an active control 
group. In theory this would permit to identify the neural correlates more specific to CBT 
itself. Unfortunately the treatments differed in their efficacy, so the findings may relate to 
different degrees of symptom resolution, rather than different cognitive strategies 
employed. The main limitation of the current study is that no wait-list control group was 
included. This would have been helpful in quantifying the degree of spontaneous, therapy 
unrelated symptomatic improvement over time and given an indication about the degree of 
efficacy of attention bias modification. At present it is difficult to disentangle the effects of 
the passage of time alone. In addition the two treatments differed not only in therapeutic 
content but also in duration, so any effects observed may be related to that.  
The three papers on the neural effects of CBT in social phobia reviewed here 
comprise the one with the largest sample size of patients and the only report that provided 
CBT over the Internet. The two studies that employed suitable methodological controls 
found some evidence that, after CBT, amygdala and PFC are less activated – unless 
patients were actively engaging in a cognitive reframing procedure, in which case 
recruitment of PFC was increased.   




This paper has reviewed thirteen functional magnetic resonance imaging studies 
that attempted to identify the neural correlates of successful CBT in patients with an 
anxiety disorder. Twelve of the thirteen studies reported original data, one (Lueken et al., 
2013) was a reanalysis of an extant dataset also reviewed here (Kircher et al., 2013). The 
overarching finding of this review is that no consistent pattern of results exists across the 
various studies.  
The quality appraisal using CONSORT criteria has also highlighted that most 
studies would have benefitted from being designed and reported in a more methodical 
manner, aiding replication, interpretability and generaliseability of findings. The 
CONSORT checklist was designed for trials of clinical efficacy. The present studies did 
not aim to establish whether CBT works and therefore using such quality criteria may be a 
slightly unfair benchmark. Nevertheless adherence to a systematic method of designing 
and reporting trials within the fields of experimental medicine or psychology criteria is 
possible in principle and would reduce the risk for reports, or at least interpretations of 
them, to be biased.  
Although by far from consistent, the highest degree of concordance across studies 
exists about the amygdala, insula and ACC: Whenever their activation changed as a 
function of psychotherapy it was always (or, in the case of the ACC, predominantly) 
reduced after CBT. Table 2 demonstrates that for the amygdala this was the case in four of 
the thirteen studies, in particular in spider phobia (Goossens et al., 2007; Hauner et al., 
2012), PTSD (Felmingham et al., 2007) and social phobia (Månsson et al., 2013). Reduced 
insula activation was also found by four studies, exclusively in spider phobia (Goossens et 
al., 2007; Hauner et al., 2012; Schienle et al., 2007; Straube, Glauer, et al., 2006). The 
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ACC showed reduced involvement after therapy in three studies of spider phobia 
(Goossens et al., 2007; Hauner et al., 2012; Straube, Glauer, et al., 2006) and one of social 
phobia (Klumpp et al., 2013). In contrast, one study found that it was more recruited 
during the processing of masked fearful facial expressions after therapy for PTSD 
(Felmingham et al., 2007). That said, it should be noted that the most consistent 
commonality across the studies reviewed here was that reduced activation in these brain 
regions was not reliably found.  
Why was an effect of CBT not seen in the amygdala more frequently? Some might 
argue that this should have been expected, given the central position of the amygdala 
within the brain’s fear network (Bishop, 2007, 2008; LeDoux, 1999). Unfortunately 
imaging the amygdala by fMRI is complicated by its comparatively small size and its 
proximity to the air filled paranasal sinuses. Magnetic field homogeneity is disrupted near 
boundaries between dense body tissue and air and BOLD signal to noise ratio is reduced 
there (Merboldt et al., 2001).  
Another concern is, however, whether the studies reviewed used the right 
neurocognitive probes to preferentially activate the amygdala in a way that is measurable 
using fMRI. The amygdala is a neural structure that habituates rapidly to stimulation, 
perhaps too quickly to be generating signal of sufficient intensity to be identified with 
fMRI scanning sequences (Dilger et al., 2003). The majority of studies used repeated slow 
presentation of visual stimuli, often not reporting whether they were perceived as 
threatening when viewed inside the bore of a large magnet in a hospital laboratory.  
Of the studies that did find reduced amygdala activation as a function of CBT, only 
half could also identify a concurrent increase of frontal cortical activation. Whilst Månsson 
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et al. (2013) found a post-therapy increase of orbitofrontal activation in social phobics, 
prefrontal cortex showed the inverse response pattern. In the insula the picture looks no 
more consistent. Schienle et al. (2007), who studied spider phobics, found that medial 
orbitofrontal cortex showed higher activation after CBT whereas lateral orbitofrontal 
cortex demonstrated reduced activation. Only Hauner et al. (2012) found that reduced 
activation of the insula corresponded with an increase in dorsolateral prefrontal activation 
after therapy. 
CBT involves the teaching of conscious cognitive strategies, such as thought 
challenging and reattribution. Therefore a popular and intuitively plausible view is that, at 
a neural level, CBT should work by increasing frontal cortical control over 
phylogenetically older subcortical limbic structures that may operate without conscious 
awareness, in particular the amygdala and insula (Beauregard, 2007; Ochsner & Gross, 
2005; Ochsner et al., 2012). In other words, some have argued that successful CBT for 
anxiety should be mirrored in reduced activation of amygdala/insula and concurrent 
upregulation of prefrontal cortex which inhibits the former structures.  
Technical, methodological and statistical limitations may account for the lack of 
consistency in observing reduced amygdala activation or increased frontal cortical top-
down modulation of deeper limbic structures as a function of symptomatic improvement. 
Based on the present body of evidence we can therefore not conclude with confidence that 
such neural mechanisms are not influenced by CBT. It has recently been suggested, 
however, that increased frontal cortical top-down control may indeed not be the way in 
which CBT for anxiety acts at a neural level: Reinecke & Harmer (in press) proposed that 
the therapy-related reduction of frontal cortical activation seen across a range of studies 
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could reflect a reduction of otherwise fear-maintaining cognitive biases such as 
hypervigilance and safety behaviours centred around avoidance.  
There is considerable consistency in the involvement of the ACC during the 
regulation of emotional arousal. Bush et al. (2000)suggested that the ACC includes 
specific processing modules for sensory, motor, cognitive and emotional information and 
integrates input from various sources including motivation, evaluation of error and 
representations from cognitive and emotional networks. They proposed that it acts by 
influencing activity in other brain regions and modulating cognitive, motor, endocrine and 
visceral responses. Accordingly, the AC C may be particularly sensitive to therapeutic 
effects that utilise top-down control of elicited emotional reactions (emotion regulation) 
but, in turn, might be less sensitive to therapeutic strategies targeted at reducing the 
bottom-up salience of the anxiety producing object (emotion elicitation). 
The majority of studies in this nascent literature was shown to have considerable 
methodological limitations, a view that was confirmed by the quality appraisal. Almost all 
studies used very low sample sizes, many with less than ten subjects in each experimental 
group. That said it is difficult to criticise this shortcoming constructively. Because 
significance testing in functional MRI does not involve a single outcome variable but 
three-dimensional brain activation maps, often using complex factorial time-series designs 
it is notoriously difficult to carry out power calculations (Hayasaka et al., 2007). No 
consensus on how this should be done exists and statistical fMRI analysis packages do not 
contain options to perform power calculations. Initial solutions have now been proposed 
that allow for power calculations in some very standard fMRI designs (Joyce & Hayasaka, 
2012; Mumford, 2012). Whilst such procedures will undoubtedly be of substantial value to 
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improve fMRI research in the future their inception was too recent to have been of benefit 
to the studies reviewed here. 
In addition to flaws with the study design, statistical weaknesses in the way data 
were analysed were also very prevalent amongst the papers reviewed. Frequently the 
significance level was insufficiently adjusted for multiple inferential statistical 
comparisons, leading to type-I-error inflation. Combined with the file drawer problem (van 
Assen et al., 2014; Vevea & Woods, 2005) this leaves one wondering whether any of the 
results of the thirteen papers reviewed are veridical (Ioannidis, 2005). Replication of the 
studies, especially by independent research groups, is thus essential to help separate true 
and consistent findings from spurious, one-off type-I-errors.  
In conclusion, the present review has been unable to identify the neural correlates 
of CBT for anxiety. No single set of unifying findings could be identified that stands out as 
representative, for example that therapy increases prefrontal cortical top-down control over 
limbic fear centres such as the amygdala. Factors that wil most likely contribute to such a 
lack of consistency are the high degree of heterogeneity across the studies reviewed: The 
samples used showed large degrees of clinical and demographic heterogeneity and so did, 
in particular, the psychotherapeutic treatments used. Studies’ methodological design was 
also very varied, in particular regarding the implementation of experimental control 
procedures  and the sample sizes deemed suitable to identify treatment effects. The review 
is further limited by the fact that it mainly assembled information in what has been 
compared to “vote-counting” (Hedges & Olkin, 1980). Ideally a meta-analytical approach 
would have been employed. However, this would have required a more consistent and 
comprehensive reporting of research methodology and results in the first place. A 
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paradigm shift towards assured quality in research reports is hopefully underway enabling 
easier comparison of clinical trials as well as experimental medicine research findings. 
It has, however, highlighted the need for future research. Both imaging 
neuroscience and psychotherapy research are still in their infancy, however (Marks, 2002). 
With the development of better neuroimaging paradigms and the further advance of 
dismantling studies that identify the effective ingredients in psychotherapy we will 
hopefully become able to integrate the two fields to help us understand how different 
components of psychotherapy work and the factors involved in their ability to reduce 
distress. Having a better understanding of what it is that makes good psychotherapy work, 
how to make it even more effective and, perhaps most importantly, allow us to better 
predict who will respond best to what type of intervention would be beneficial in deciding 
how to allocate scarce clinical resources and where to spend research funding. Whether 
functional MRI will become a routine part of clinical screening remains to be seen. It is 
currently too time and resource expensive to be viable to become a standard clinical 
assessment tool. However, the further development of quicker tests, such as structural MRI 
or electrophysiological measures such as electroencephalogram or evoked potentials may 
be developed to give test results of good enough predictive validity to be useful in 
everyday clinical decision making about whom to offer what type of intervention to 
combat anxiety disorders. 
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A Randomized Controlled Trial of the Neural Effects of Cognitive Behavioural 
Therapy for Panic Disorder  
 
  




Background: Cognitive behavioural therapy (CBT) is an effective treatment for panic 
disorder. However, little is known about whether and how neural processing of threat 
changes following CBT. Aim: To identify the effects of CBT for panic disorder on brain 
mechanisms involved in threat processing using a wait-list control group. Method: In a 
randomised controlled trial 28 participants with panic disorder were allocated to receive 
brief CBT or to wait for treatment for the same amount of time. After treatment or waiting 
participants had a functional magnetic resonance scan of their brain while they were 
viewing aversive and threatening pictures. Neural activations were measured in two 
conditions – when participants maintained their negative affect or used cognitive 
reappraisal strategies to reduce affect. Results: Brief CBT was highly effective in reducing 
clinical symptoms of anxiety. Neuroimaging identified that CBT reduced responsivity of 
dorsolateral and dorsomedial prefrontal cortex to threatening images. CBT reduced threat-
related activation in the amygdala only when participants maintained the affect induced by 
the aversive pictures and not when they employed cognitive reappraisal strategies. 
Conclusions: Fronto-limbic responsivity to threat is reduced by brief CBT in panic 
disorder. These results highlight relevant neurobiological mechanisms of CBT which may 
be important for future treatment development and treatment combination approaches.  
  




Panic disorder is one of the most prevalent anxiety disorders (Kessler et al., 2006). 
Its hallmark is the occurrence of unexpected panic attacks – sudden-onset episodes of 
intense fear during which the sufferer believes that a physical, mental or social catastrophe 
is imminent (American Psychiatric Association, 2013). Panic disorder is not only highly 
distressing for those who experience it but also presents a significant socioeconomic 
burden because morbidity, chronicity and associated disability are high (Yonkers et al., 
2003).  
The psychological factors involved in the development and maintenance of panic 
disorder are well understood (Clark, 1986) and effective treatments have been developed 
(Gelder et al., 1993). Clinical guidelines now recommend cognitive-behavioural therapy 
(CBT) as a first line treatment above pharmacological or other interventions (NICE, 2011). 
However, a significant proportion of those treated fails to respond to CBT or relapses after 
discharge from therapy (McHugh et al., 2009; Otto et al., 2000). Furthermore, only a 
minority of people with panic disorder has good access to CBT. Understanding the 
mechanisms underlying successful treatment of panic disorder may help to develop faster 
acting and more specific therapy programmes, devise better combination approaches 
(using pharmacological as well as psychological strategies) and identify individual 
differences which predict the likelihood of treatment efficacy before its resource intensive 
application. 
The amygdala, a subcortical nucleus in the pole of the temporal lobe, has long been 
identified as an essential neural substrate in the recognition of threat and the generation 
and maintenance of fear (Klüver & Bucy, 1937; LeDoux, 1999; Rolls, 2007). Gorman et al. 
(Gorman, Kent, Sullivan, & Coplan, 2000) reviewed a large body of animal and human 
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neuroscience research and proposed that panic attacks are mediated by a similar fear 
network in the brain that is involved in fear conditioning. They suggested that this network 
consists of the amygdala and its interactions with the hippocampus and medial prefrontal 
cortex. Physical reactions like those seen in conditioned fear responses were proposed to 
be mediated by the hypothalamus and brainstem sites that receive afferents from the 
amygdala. Bishop (2007, 2008) reviewed cognitive research into the neural substrates of 
anxiety based on a range of human neuroimaging studies that were mainly conducted on 
PTSD as well as in healthy individuals with high levels of state or trait anxiety. She 
concluded that the amygdala acts as a threat detector whose stereotyped and automatic 
action is brought under top-down control by the prefrontal cortex. In untreated anxiety, this 
circuit seems imbalanced, with excessive amygdala responsivity to threat not being 
sufficiently regulated by higher cortical areas. Thus, interactions between the amygdala 
and the prefrontal cortex appear to play a central role in the generation, maintenance and 
control of anxiety. 
Pharmacological treatments used for anxiety have been shown to modulate 
prefrontal-amygdala circuits during threat processing. For example, selective serotonin 
reuptake inhibitors (SSRIs) and benzodiazepines, which are used in the management of 
anxiety, reduced amygdala responses during the presentation of negative facial expressions 
of emotion in healthy volunteers (Del-Ben et al., 2012; Harmer et al., 2006; Murphy et al., 
2009). SSRI treatment also resolved the imbalance in prefrontal cortex (PFC) – amygdala 
responses seen in people with social anxiety disorder during the processing of negative 
facial cues (Phan et al., 2013). However, comparatively little is currently known on 
whether successful CBT for panic disorder influences the neural processing of threat and 
fear. 
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During the past decade a number of neuroimaging studies investigated the neural 
correlates of psychotherapy for panic disorder. Using positron emission tomography (PET) 
to measure resting state brain glucose metabolism, Sakai et al. (2006) found that successful 
CBT was related to a modulation of glucose uptake in the hippocampus, medial prefrontal 
cortex and anterior cingulate cortex during rest. Unfortunately no control group was used 
and thus the effects of CBT cannot be differentiated from nonspecific effects. 
Using fMRI, Kircher et al. (2013) reported that people with panic disorder 
exhibited a significantly higher activation in the left inferior frontal gyrus during aversive 
classical conditioning trials, which normalised after CBT. Lueken et al. (2013) reanalysed 
the same data set but focussed on differences between responders and nonresponders to 
CBT. They found that non-response to future CBT was best predicted by increased 
activation in the right ACC, the hippocampus and the amygdala when, within the same 
classical conditioning paradigm, participants were processing a stimulus that was not 
followed by an unpleasant burst of white noise (i.e., a safety signal). These results suggest 
potential effects of CBT on neural circuits engaged during threat processing in people with 
panic disorder. However, the conclusions which can be reached are seriously compromised 
by the absence of an equally symptomatic control group that would have allowed to 
determine the effects of repeated testing in this paradigm or the influence of nonspecific 
therapy effects. The relevance of the aversive conditioning paradigm to panic disorder is 
also questionable and clearer results may be seen with a paradigm more closely related to 
the nature of threat bias seen in panic disorder. 
A recent fMRI study explored the neural correlates of emotional regulation during 
the presentation of aversive and physically threatening images in people with panic 
disorder compared to healthy controls (Reinecke et al., in press). Two conditions were 
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compared: the normal emotional experience to the stimuli versus the response when 
participants applied cognitive reappraisal strategies. During the normal experience of 
threatening pictures, people with panic disorder showed increased activation of the 
amygdala, dorsomedial and dorsolateral PFC. These differences were resolved when 
participants were reappraising the content of the images. These findings are consistent with 
the idea that the amygdala may be over-sensitive in people with panic disorder. But they 
also raise additional insights into the neural architecture of panic. Instead of showing 
impaired recruitment of prefrontal cortex, participants with panic disorder showed elevated 
responses there. This implies that they were able to engage neural circuits involved in 
emotion regulation but that this engagement did not resolve the amygdala hyperarousal. 
Reinecke & Harmer (in press) suggested that this may signify the use of unhelpful safety 
behaviours in attempts to control the emotional response. However, when people with 
panic had been taught helpful reappraisal strategies they were able to modulate the 
response in limbic areas, perhaps implying that PFC circuits may indeed be functioning 
well in people with panic once they are given effective cognitive tools.  
Reinecke et al (in press) have shown that untreated people with panic disorder can 
make good use of effective cognitive strategies once these are provided, but until then 
unhelpful strategies may be applied instead. The present study aimed to expand on these 
results by using the same emotion regulation paradigm to assess the clinical as well as 
neural effects of a short course of CBT compared to a waiting list control group in people 
with panic disorder. The neural effects were assessed using a whole brain analysis as well 
as a region of interest around the amygdala, based on the results of Reinecke et al (in 
press).  
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Our primary hypothesis was that CBT would reduce engagement of the amygdala 
during threat processing, particularly during the maintain emotion condition. This 
hypothesis was based both on the effects of pharmacological interventions used in anxiety 
disorders (Harmer et al. 2006) as well as on evidence for overactivation of this area in 
panic disorder (Reinecke et al., in press). Similarly, as a secondary hypothesis, we 
predicted that short-term CBT would be effective in reducing overactivation of the 
dorsomedial and dorsolateral PFC during the maintenance of emotion. In the reappraisal 
condition we expected to find fewer effects of treatment given that previously no 
differences in neural processing was found in such a task when comparing untreated 
people with and without panic disorder (Reinecke et al, in press). It was also hypothesized 
that the brief CBT would show clinical efficacy by alleviating panic disorder symptoms in 
those participants randomised into the treatment group. 
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Materials and Methods 
Study Design 
The present study used a parallel trial design. Half of all participants were assigned 
to a CBT treatment group (TG) and half to a waiting group (WG) not receiving any 
interventions until after the experimental procedures. 
Participant recruitment 
Potential volunteers were informed about the study via advertisements (in local 
newspapers, radio broadcasts, on facebook.com, on dailyinfo.com, posters around town 
and in GP practices) In addition, patients waiting to access the Lupina Service, a group of 
graduate psychologist volunteers trained in delivering CBT for panic disorder based at the 
Warneford Hospital, Oxford, were invited to enrol in the study. Oxfordshire GPs were sent 
information about the study. 
Interested participants were asked to complete an online screening of around 10 
minutes duration. This included the Panic Disorder Severity Scale (PDSS) to assess the 
severity of panic symptoms as well as the Hospital Anxiety and Depression Scale (HADS). 
In excess of 300 people completed this. To be considered for inclusion in the study, 
volunteers had to be aged between 18 and 70 years, be sufficiently fluent in English to 
understand the task and instructions, have a PDSS score of six or higher and have 
experienced at least two full panic attacks or limited symptoms attacks during the 
preceding four weeks. Volunteers were unable to enrol in the study if they were left-
handed (to minimise variability due to differences in brain lateralisation), pregnant, had 
contraindications to MRI (such as metal implants) or a lifetime history of epilepsy, heart or 
respiratory problems (to ensure participant safety), alcoholism, psychotic or bipolar 
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disorder (to reduce variability due to clinical complexity), substance abuse (to ensure 
participant safety and to reduce variability due to clinical complexity), treatment with 
antidepressant medication during the last 6 months (to maximise possible specificity of the 
treatment offered here) and having previous received CBT (since this may have masked 
potentially subtle effects of the very brief treatment offered here). 
 62 eligible volunteers were interviewed by a qualified clinical psychologist using 
the clinician version of the Structured Clinical Interview for DSM-IV Axis I Disorders, 
SCID-CV (First et al., 1996). A diagnosis of panic disorder could be established in 28 
volunteers who were enrolled in the study.  
Occasional use of benzodiazepine or beta-blocker medication, which was defined as 
prescribed to patients as pro re nata (PRN) to help with symptoms only when they felt 
panicky, was not an exclusion criterion but patients refrained from these drugs 48 hours 
before treatment and scanning sessions. Five members of the TG and two of the WG were 
benzodiazepine users, one member of the WG and none of the TG took beta blockers. 
Ethical approval was obtained from the local research ethics committee (National Research 
Ethics Service, Oxfordshire REC A, reference number 09/H0604/55). All participants gave 
written informed consent.  
Collection of behavioural data took place at the Neurosciences section of the Department 
of Psychiatry, Warneford Hospital, Oxford and functional imaging data were acquired at 
the University of Oxford Centre for Clinical Magnetic Resonance Research, John 
Radcliffe Hospital, Oxford. 





Participants in the TG and, after the waiting period had passed, those of the WG 
were given individual CBT that was provided by graduate volunteer, research and trainee 
clinical psychologists who had been trained in Clark’s protocol for brief cognitive therapy 
for panic disorder (Clark et al., 1999). This treatment programme has been shown to be as 
effective as standard CBT which would typically last between twelve and fifteen sessions 
(Clark et al., 1994; Gelder et al., 1993). It is based on the assumption that panic disorder 
develops as a consequence of neutral sensations (e.g., increased heart rate) being 
misperceived as threatening (e.g., having a heart attack), and safety strategies (e.g., leaving 
the situation, calling a friend) being developed to reduce the perceived danger. Safety 
behaviours are reinforced because they reduce anxiety but at the same time preclude the 
experience of corrective experiences (e.g., realising that they would not have died of a 
heart attack if they had remained in a crowded supermarket after physical symptoms 
began).  
Therapy consisted of weekly sessions of 60 minutes’ duration and was delivered 
over the course of four weeks. It was based on and adapted from the protocol by Clark et al. 
(1999). A typical session plan was as follows. 
Assessment session: Presenting problems, brief personal history, therapy goals, 
development of a therapeutic alliance, a typical panic attack, avoidance and safety 
behaviours. Homework: Psychoeducation by reading a booklet on panic disorder provided 
by the local Oxford Cognitive Therapy Centre (OCTC) that covered the cognitive 
approach to panic disorder and the vicious cycle of panic (Clark, 1986). 
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Therapy session1 : Collaborative development of a maintenance formulation based 
on the cognitive model of panic (Clark, 1986) using a typical or recent panic attack. 
Identification of idiosyncratic safety behaviours, avoidance strategies. Socratic dialogue on 
how these serve as perpetuating factors. Catastrophic beliefs about (the typically physical) 
symptoms of panic. Evidence for and against these beliefs. Homework: Keep panic diary 
with emphasis on recording catastrophic thoughts and associated belief ratings when 
experiencing panic symptoms. 
Therapy session 2: Review of thought records. Collaborative development of 
idiosyncratic panic circle (maintenance formulation) using these. Discourse on 
catastrophic versus harmless alternative explanations for panic symptoms. Socratic 
dialogue aimed at understanding how avoidance and safety behaviours act as barrier to 
discovering whether the feared catastrophe could occur in reality or if the outcome could 
instead be harmless. Homework: Keep panic diary with particular emphasis on fears of 
symptoms and how these could be tested.  
Therapy session 3: Review of panic diary and key feared symptoms. Discourse on 
the specific role of avoidance and safety behaviours. Derivation of how it could be tested 
out whether these symptoms have awful consequences or not. Introduction of the notion of 
guided discovery and socialisation to exposure as therapeutic mechanism. In-session 
provocation of (a) highly-feared symptom(s), typically by hyperventilating or vigorous 
aerobic exercising. Homework: Keep panic diary, seek out triggers to panic attacks (also 
using symptom provocation techniques), resist urge to use avoidance/safety behaviours.  
Therapy session 4: Review of homework. Further practice using symptom 
provocation. Summary of personal development over course of therapy. Completion of a 
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relapse prevention/management plan, focusing on the maintenance of exposure and 
identification of unhelpful use of safety behaviours and avoidance.  
Clinical supervision was provided by a chartered clinical psychologist and 




The primary outcome of this study was the neural activation patterns in response to 
viewing negative-affect inducing pictures whilst maintaining that affect versus managing it 
by cognitively reappraising the content of the pictures. It was assessed using an fMRI scan 
of the participants’ brains. Even though this study was not aimed at verifying the efficacy 
of the therapeutic intervention, clinical symptoms can nevertheless serve as a useful 
secondary outcome  
Primary outcome: fMRI measures 
Participants were brain scanned after four sessions of brief CBT (TG) or after 
waiting the same amount of time (WG). 40 coloured images of negative valence from the 
International Affective Picture Series (IAPS, Lang et al., 2008) were presented in 8 blocks 
of 5 images, one after another, for 5s each. They depicted characteristic panic-related 
catastrophic expectations, such as accidents, funerals and medical procedures. IAPS 
picture numbers used were as follows: Block 1, 9600, 2053, 3022, 6350, 9592; Block 2, 
9622, 9912, 6212, 6360, 6300; Block 3, 1300, 9800, 6838, 6560, 6940; Block 4, 6312, 
9250, 1050, 9920, 2691; Block 5, 9910, 6821, 3030, 3230, 6510; Block 6, 1930, 6570, 
6370, 9911, 8480; Block 7, 2100, 6550, 9921, 9001, 1201; Block 8, 6540, 2751, 2141, 
2120, 6211. The normative sample in the study by Lang et al. (2008) had given mean 
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valence ratings for these images of 2.8 ± 1.7 and mean arousal ratings of 6.0 ± 2.2 on 9-
point Likert scales ranging from 1 (unpleasant or low arousal, respectively) to 9 (pleasant 
or high arousal, respectively). Valence and arousal ratings as well as scene content were 
matched between the two experimental conditions, Maintain and Reappraisal.  
The order of picture blocks remained constant across participants. Experimental 
conditions alternated between blocks and were pseudo-randomised so that half of the 
subjects per group started with a Maintain and half with a Reappraisal block. In Maintain 
blocks, participants were instructed to respond naturally to the images without attempting 
to consciously regulate or alter the emotional state they experienced. In Reappraisal blocks, 
they were instructed to down-regulate the provoked negative affect by using strategies of 
cognitive reappraisal (e.g., reframing or rationalising). These strategies had been trained 
before the scan. Experimental conditions were cued prior to each block by presenting the 
word MAINTAIN or REAPPRAISE on the screen for 4s. To evaluate effectiveness of the 
reappraisal task a 4-point rating scale (1= neutral, 4= negative) was presented for 4s at the 
end of each picture block, and participants indicated the intensity of negative affect they 
experienced across the past block using a keypad. Figure 1 shows a schematic sketch of a 
typical timeline of stimuli experienced by a participant in the brain scanner. 




Figure 1. A sample timeline of visual stimuli. Sequences of affective pictures lasted 25s 
and alternated with baseline periods during which a fixation target was presented on a grey 
screen, also for 25s. Picture blocks consisted of successive presentations of five affective 
pictures and were preceded by a word cue that instructed participants whether to maintain 
their emotional experience or regulate it by cognitively reappraising the content of the 
pictures. At the end of each picture block participants rated how negative their affect had 
been on a scale ranging from 1 to 4. Maintain and reappraisal blocks alternated until a total 
of eight blocks was completed. 
 
Prior to the fMRI scan, and using IAPS images different from those presented 
during the experiment, participants were trained to apply reappraisal strategies effectively. 
It was emphasized not to look away from the images and not to generate thoughts 
unrelated to the images as a means of distraction. The experimenter introduced emotion 
regulation strategies by presenting two sample images and modelling verbal reappraisal, 
such as positive reframing (e.g., interpreting the scene of a middle-aged woman in a 
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hospital waiting room as her waiting either to hear whether her husband could be saved or 
to visit her newborn grandchild) or rationalising (e.g., interpreting the tears of a child as 
signs of tiredness instead of grief). Participants then practised reinterpreting three images 
aloud. Reappraisal training took place immediately prior to the brain scans. It lasted 
between 5 and 10 minutes. It was separate from techniques taught in CBT in that explicit 
cognitive reappraisal of distressing pictorial material had not been practised by the TG 
during their therapy sessions. Another pre-scan practice consisted of presenting complete 
example Maintain and Reappraisal blocks together with fixation baselines and valence 
rating tasks until participants were familiar with the task and had no more questions. 
MR Image Acquisition 
Images were obtained using a 3T Siemens Sonata MRI scanner. T2*-weighted 
functional data were acquired for a whole-brain field-of-view (64x64x40 matrix), with a 
voxel resolution of 3mm3, repetition time (TR) of 3.0s, echo time (TE) of 30ms and a flip 
angle of 90 degrees. Field maps were acquired using a dual echo 2D gradient echo 
sequence with echoes at 5.19ms and 7.65ms, respectively, and a repetition time of 500ms. 
High-resolution T1-weighted structural MR images were acquired for subject alignment 
using an MPRAGE sequence with the following parameters with a 174x192x192 matrix, a 
voxel resolution of 1mm3, a TR of 2.04s, a TE of 4.7ms and an inversion time (TI) of 
900ms.  
 
Secondary outcome: Clinical scores 
At baseline as well as after four sessions of brief CBT (TG) or waiting (WG), participants 
completed the Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983), 
the Body Sensations Questionnaire (BSQ; (Chambless, Craig, Bright, & Gallagher, 1984) 
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and the Agoraphobic Cognitions Questionnaire (ACQ; Chambless et al., 1984). The 
HADS has 14 items, is quick to complete, frequently used in clinical research and has 
good reliability (Crawford, Henry, Crombie, & Taylor, 2001). Both the BSQ and the ACQ 
are detailed screening checklists of typical physical symptoms and cognitive biases 
experienced in panic disorder. They have been reported to have good validity and 
reliability and have frequently been used in clinical trials of treatments for panic disorder 
(Chambless et al., 1984; D M Clark et al., 1999; Ehlers et al., 2003). 
 
Sample size 
Because significance testing in functional MRI does not involve a single outcome variable 
but three-dimensional brain activation maps, sample size calculations based on expected 
effect sizes pose substantial statistical problems (Hayasaka et al., 2007). When the study 
was designed no statistically validated method of determining the sample size existed. 
Therefore the following rationale was applied. Functional imaging work by the same group 
had shown that antidepressant medication can alter the neural response signatures 
associated with cognitive processing of threat (Harmer et al., 2006). There twelve 
participants in either of two experimental groups was sufficient to produce reliable fMRI 
signal change in the amygdala. Antidepressant medication not only reduces amygdala 
response to threat but is also used to treat panic disorder. We therefore anticipated that 
CBT may have a similar effect, justifying a similar sample size. To allow for greater 
variability of the mechanisms of action of a talking treatment we decided to test a total 
sample of 28 participants. 
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Randomisation, matching and blinding 
Participants enrolled in the study were numbered consecutively (1, 2, 3, etc). Before the 
start of the study they were randomly allocated to the groups in blocks of four such that, 
e.g., of participants 1-4 two would be allocated to the TG and two to the WG. Whenever 
too many participants of one gender accumulated in one group compared to the other, a 
participant would automatically be swapped to the opposite group, ensuring groups were 
matched for gender. Randomisation, allocation and implementation were carried out by a 
senior postdoctoral research assistant. No mechanisms were employed to blind participants 
as they would of course always know whether they had waited or received therapy. fMRI 
pre-processing occurred without knowledge of participant group membership. Further data 
analysis employed coded participant numbers with no link to individual identifiers. 
 
Statistical methods 
Analysis of fMRI data  
Pre-processing 
Functional MRI scans require a degree of pre-processing to maximise signal-to-noise and 
to ensure correct anatomical alignment of activation signals with actual brain tissue. Over 
the duration of a scan participants move their head slightly. To account for this a motion 
correction was applied (Jenkinson et al., 2002) in which images were spatially realigned. 
In a next step any image voxels that did not consist of brain tissue (e.g. the skull) were 
removed from the images (Smith, 2002). Spatial smoothing reduces local noise and 
increases statistical power. This was done using a Gaussian kernel of 5.0mm full width at 
half maximum. Subsequently the entire 4-dimensional dataset was normalised for its 
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overall intensity values. Activation data were then co-registered onto the anatomical 
template of the Montreal Neurological Institute (MNI) standard brain template 152 (Brett, 
Johnsrude, & Owen, 2002). For technical reasons the spatial distribution of the magnetic 
fields inside a brain scanner is not homogenous. Further, MRI signal varies over time, 
again due to the physical properties of an MRI scanner. Slow signal drifts arising from this 
were reduced using high pass temporal filtering (by Gaussian-weighted least-squares 
straight line fitting with a standard deviation of 50.0s). Spatial field inhomogeneities were 
accounted for using the field map correction function  
Image Analysis 
Functional imaging data consist not of a single data point per measurement but of a 
three-dimensional array of BOLD signal contrast values in a time series of numerous 
measurements per second across experimental conditions. A standard way of analysing 
such data is to model the experimental procedure an individual participant experienced 
over the time he or she spent in the scanner. Software packages generate a hypothesised 
time course of brain activation signal change depending on the experimental design. This 
expected time series is then fitted to individual data to determine whether and where in the 
brain significant activation differences across experimental conditions and other covariates 
of interest are seen.  
In contrast to behavioural research paradigms, fMRI data analysis is performed 
using mass-univariate approaches. Statistical inferences are made at the level of voxels or 
clusters of voxels and involve separate independent statistical tests. Such extensive 
inferential statistical testing comes at the expense of type-I-error inflation and requires 
control. One way to do so is to apply cluster-extent based thresholding (Woo, Krishnan, & 
Wager, 2014). This method detects statistically significant clusters on the basis of the 
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number of contiguous voxels whose voxel-wise inferential statistic values lie above a pre-
determined primary threshold. In contrast to voxel-wise approaches, such as Bonferroni 
correction, cluster-based approaches have comparatively higher sensitivity and do not 
make the a-priori assumption that adjacent voxels are independent from one another. Since, 
by virtue of their spatial proximity, they are in fact autocorrelated, assuming independence 
would over-correct for type-I-error inflation and reduce statistical power more than needed.  
Functional imaging data were analysed using the FEAT toolbox of the FMRIB 
Software Library 6.0. (Jenkinson et al., 2012). In this software, a primary cluster detection 
threshold of Z=2.3 is the default setting and is frequently used as a standard in fMRI 
research (Woo et al., 2014). Z-statistic brain activation maps were thus thresholded at 2.3, 
equating to a threshold of p < .05.  
Event-Related Analysis 
. At the first level, data were analysed using a general linear model approach with 
local autocorrelation correction (Woolrich, Ripley, Brady, & Smith, 2001). Two regressors 
of interest (Maintain and Reappraisal) and two regressors of no interest (instruction 
periods and rating periods) were included. Fixation blocks, presented between picture 
blocks, served as baseline reference. Contrast images were calculated for picture blocks in 
general, Maintain blocks, Reappraisal blocks, Maintain versus Reappraisal, and 
Reappraisal versus Maintain. These individual activation maps were then analysed at 
group level (TG, WG), using a mixed-effects analysis across the whole brain (Beckmann 
et al., 2003).  
Region of Interest Analysis 
Recently Reinecke et al. (in press) identified the amygdala as hyperactive in 
incidental (Maintain) versus volitional (Reappraisal) emotion regulation in panic disorder. 
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Based on these results a region of interest (ROI) analysis was computed. The ROIs were 
defined by spherical masks with a radius of 10mm that were centred around the peak voxel 
of a left amygdala region (MNI coordinates -14 ,-6, -8) as well as its right-hemisphere 
counterpart. 
Significant whole-brain or ROI interactions were explored by extracting percent 
blood oxygenation level-dependent (BOLD) signal changes within these areas and entering 
them into Group (TG, WG) x Task (Maintain, Reappraisal) split-plot ANOVAs with t-tests 
for follow-up where appropriate. 
Analysis of clinical scores 
 Questionnaire composite scores for each participant were entered into separate 
Group x Time split-plot ANOVAs for each measure. Significant interactions or main 
effects were followed up by way of post-hoc comparisons using paired or independent t-
tests as appropriate. 
Analysis of efficacy of reappraisal training 
Participants’ ratings of negative affect experienced when viewing the affective 









Table 1 shows the demographic composition of both samples. Independent samples 
t- or X2-tests showed that TG and WG did not differ from each other (all p>/=.48). 
Participants completed the Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983), the Body Sensations Questionnaire (BSQ; Chambless et al., 1984) and the 
Agoraphobic Cognitions Questionnaire (ACQ; Chambless et al., 1984).  
Table 1. Demographic and clinical composition of the experimental groups at baseline 
(mean ± SEM; p-values from independent samples t- or X2-tests; NART, National Adult 
Reading Test; PDA, panic disorder with agoraphobia; PD, panic disorder without 
agoraphobia; SP, social phobia; SPP, specific phobia).  
 Treatment Group Waiting Group p 
Age 34.8 ± 3.9 37.2 ± 3.0 .63 
Gender 8 female/ 6 male 10 female/ 4 male .70 
Years of education 15.2 ± 0.7 15.8 ± 0.7 .56 
Verbal IQ (NART) 118.0 ± 1.3 116.6 ±1.5 .48 
Primary diagnosis 10 PDA/ 4 PD 8 PDA/ 6 PD .70 
Comorbid diagnoses 2 SP/ 2 SPP 1 SP/ 3 SPP .77 
 
Table 2 contains the clinical symptom measures taken and shows that these did not 
differ between the groups at baseline (all p >/= .51). On the HADS, both groups scored 
within the ‘moderate’ range for anxiety and within the ‘mild’ range for depression 
(Zigmond & Snaith, 1994). Scores for both the BSQ and the ACQ exceeded those of a 
normative clinical population (Bibb, 1988).  
Table 2. Clinical symptom severity of the experimental groups at baseline (mean ± SEM; 
p-values from independent samples t-tests; HADS, Hospital Anxiety and Depression Scale; 
BSQ, Body Sensations Questionnaire; ACQ, Agoraphobic Cognitions Questionnaire) 
 Treatment Group Waiting Group p 
HADS - anxiety 14.4 ± 1.1 13.4 ± 1.0 .51 
HADS - depression 8.4 ± 1.2 9.1 ± 1.0 .62 
BSQ 3.4 ± 0.1 3.4 ± 0.2 .75 
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ACQ 2.5 ± 0.2 2.3 ± 0.2 .54 
 
 
Clinical Scores: effects of intervention 
Group x Time split-plot ANOVAs revealed significant interactions for all clinical 
scores (HADS –anxiety: F = 212.16, df = 1,26, p < .001; HADS –depression: F = 95.16, df 
= 1,26, p < .001; ACQ: F = 3.77, df = 1,26, p < .001; BSQ: F = 8.73, df = 1,26, p < .001). 
These interactions were further explored using follow-up t-tests. As above, at baseline no 
differences existed between groups (all p>.51, see Table 2). Table 3 shows that over the 
four-week course of CBT there was a significant reduction of anxiety and depression 
(HADS), fear of physical sensations (BSQ), and agoraphobic cognitions (ACQ) in TG 
(paired-samples t-tests, all p </= .001) but not in WG (paired-samples t-tests, all p > .3). 
After CBT, or the according wait, TG had significantly reduced clinical symptom scores 
when compared to WG using independent t-tests (all p<.001) After therapy, both TG 
HADS scores had reduced to within the normal range (Zigmond & Snaith, 1994) and those 
of the BSQ and ACQ were at, or slightly below, the mean levels of a normative non-
clinical community sample (Bibb, 1988). 
 
Table 3. Clinical symptom severity of the experimental groups at baseline and after 
treatment or after a four-week waiting period (mean ± SEM; p-values in normal typeface 
from paired t-tests, comparing clinical scores pre- vs. post CBT or wait; p-values in bold 
typeface from independent samples t-tests, comparing groups after CBT or wait; HADS, 
Hospital Anxiety and Depression Scale; BSQ, Body Sensations Questionnaire; ACQ, 
Agoraphobic Cognitions Questionnaire). 
 Treatment Group  Waiting Group   
 Baseline After 
CBT 
p Baseline After wait p p 
HADS - anxiety 14.4 ± 1.1 6.1 ± 1.1 <.001 13.4 ± 1.0 12.9 ± 0.9 .47 <.001 
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HADS - depression 8.4 ± 1.2 2.6 ± 0.7 <.001 9.1 ± 1.0 8.6 ± 1.0 .36 <.001 
BSQ 3.4 ± 0.1 1.8 ± 0.2 <.001 3.4 ± 0.2 3.3 ± 0.2 .61 <.001 
ACQ 2.5 ± 0.2 1.5 ± 0.1 .001 2.3 ± 0.2 2.4 ± 0.2 .72 <.001 
 
Efficacy of reappraisal task 
 Due to technical difficulties negative affect ratings could not be obtained in two of 
the 14 TG participants. In the TG, mean (±SEM) negative affect ratings when viewing 
IAPS pictures were 2.68 (0.25) when maintaining affect and 1.60 (0.24) during reappraisal. 
Corresponding values for the WG were 2.56 (0.25) in maintain and 1.85 (0.20) when 
reappraising. ANOVA detected no interaction between group and task (F < 1, df = 1,24, 
n.s.), nor were groups found to differ from one another (F < 1, df = 1;24, n.s.). However, a 
main effect of task was found, showing a highly significant reduction of negative affect 
when reappraising the pictorial content (F = 16.1; df = 1;24, p < .001). 
Whole-Brain Analysis 
Main effect of task (Reappraisal versus Maintain, across both groups 
combined). In line with previous work (Reinecke et al., in press), reappraising the threat 
associated with the IAPS stimuli was associated with increased activation in bilateral areas 
of dorsal ACC, dorsomedial PFC, dorsolateral PFC, ventrolateral PFC, orbitofrontal cortex, 
and insula (18201 voxels, MNI coordinates -4, 24, 44, Z = 5.15), bilateral cerebellum 
extending into occipital fusiform gyrus (left: 406 voxels, MNI coordinates -54, -60, -32, 
Z = 3.39; right: 1557 voxels, MNI coordinates 32, -62 ,-52, Z = 4.53), and bilateral angular 
gyrus (left: 355 voxels, MNI coordinates -48, -40, 30, Z = 3.86; right: 507 voxels, MNI 
coordinates 54, -48, 48, Z = 4.07).  
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Main effect of group (picture blocks versus baseline). Compared to WG, TG 
showed significantly reduced activation in bilateral dorsomedial PFC and left dorsolateral 
PFC during the eight picture blocks versus the fixation screen baseline (540 voxels, MNI 
coordinates -2, 36, 60, Z=4.59; main sub-regions within this cluster: MNI coordinates -36, 
38, 42, Z=3.52, MNI coordinates 2, 46, 50, Z=3.46) (Figure 2).  
 
 
Figure 2. Main effect of Group: Compared to the waiting list group (WG), participants in 
the treatment group (TG) showed significantly reduced activation in left and right 
dorsomedial PFC and left dorsolateral PFC during picture blocks (versus fixation baseline 
blocks). Error bars show SEM. 
 
Group x task interaction (Maintain versus Reappraisal). Figure 3 depicts a 
significant Group x Task interaction in the left middle and superior temporal gyrus cluster 
(356 voxels, MNI coordinates –58, -4, -10, Z=4.53). Post-hoc analyses on BOLD signal 
change extracted from this cluster indicated that this interaction was driven by inverse 
differences in activation across groups during Maintain and Reappraisal Blocks (ANOVA 
Task x Group F = 39.40, df = 1,26, p < .001), with TG showing significantly reduced 
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activation compared to WG in Maintain blocks (t = 3.24, df = 26, p = .003) and relatively 
increased activation in Reappraisal blocks (t = 2.42, df = 26, p < .05). 
 
 
Figure 3. Group x Task interaction: Maintaining negative affect (versus reappraisal) was 
associated with attenuated signal response in treated compared to untreated participants in 
the left superior-middle temporal gyrus. Images thresholded at Z > 2.3, p < 0.05, corrected. 
Error bars show SEM. 
 
Amygdala Region of Interest Analysis 
A hemisphere x Group x Task ANOVA on BOLD percent signal change extracted 
for the left (Maintain: TG .06 ± .34, WG .37 ± .46; Reappraisal: TG .28 ± .28, WG .15 
± .31) and right amygdala (Maintain: TG .03 ± .36, WG .33 ± .58; Reappraisal: TG .27 
± .53, WG .12 ± .25) spheres showed no significant laterality effect. Pooled across 
hemispheres a significant Group x Task interaction was found (F = 6.45, df = 1,26, p < 
0.05). As Figure 4 demonstrates, this effect was driven by TG showing reduced activation 
compared to WG in Maintain blocks (p < 0.05), but not in Reappraisal blocks (p = .29).  
 




Figure 4. Region of interest analysis in left and right amygdala regions of interest: 
Participants showed reduced bilateral amygdala activation during Maintain blocks when 
they had completed treatment (TG) but not when they had been on the waiting list (WG). 
Error bars show SEM. 
 
  




In this study four sessions of CBT were highly effective and led to significant 
improvements in panic severity, anxiety and mood compared to the waiting list control 
group. Emotion regulation was associated with increased engagement of prefrontal cortex. 
Participants receiving CBT showed reduced amygdala response during normal emotional 
viewing of aversive pictures as well as reduced responses in the dorsolateral and 
dorsomedial PFC during aversive picture presentation. These results support the view that 
aberrant neural processing of threat in panic disorder may have been normalised following 
CBT. 
A Brief CBT Programme 
Clinical guidelines recommend that the optimal duration of CBT for panic disorder 
should range from seven to twelve hours (NICE, 2011). The present study used a relatively 
brief programme of four sessions of CBT, which was also shown to be highly effective, in 
line with our hypothesis as well as affirming the results of Clark et al. (1999). Recent work 
suggests that even a single session of CBT can reduce symptoms measured after four 
weeks – although not immediately after therapy (Reinecke et al., 2013). These findings 
suggest that the effects of CBT develop over time and it is possible that when the right 
treatment paradigms are deployed maximal clinical efficacy may be achieved with a much 
lower frequency and intensity of interventions than previously thought. It would therefore 
be interesting to carry out a longer term follow up with the participants treated here to see 
whether the therapy benefits seen after four weeks may have endured or possibly even 
increased over time. 
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The Neural Effects of CBT 
The amygdala and dorsomedial PFC. The amygdala plays a central role in the 
detection and response to threat and is believed to be involved in the pathophysiology of a 
number of different anxiety disorders (Bishop, 2007, 2008; LeDoux, 1999; Rolls, 2007). 
Previous work in panic disorder supports the hypothesis that the amygdala is hyper-
responsive during threat processing compared to healthy controls (Reinecke et al., in press). 
These effects are consistent with increased sensitivity to benign threat cues in the disorder. 
The current study further suggests, in line with our primary hypothesis, that amygdala 
hyper-arousal is normalised following a brief course of CBT compared to a matched 
sample of participants in a waiting list condition. This effect is similar to that seen with 
pharmacological treatment used for anxiety disorders suggesting a potential overlap in the 
neural mechanisms of action (Harmer et al., 2011). It is also consistent with behavioural 
evidence for an early reduction in vigilance to threat seen after only a single session of 
CBT (Andrea Reinecke et al., 2013). Attentional bias to threat is believed to rely on 
amygdala based circuits and in this study, reduced vigilance to threat was predictive of 
later improvements in symptoms of panic and agoraphobia. Therefore it is possible that 
changes in the processing of threat might be an important mechanism underlying 
therapeutic gains. 
The dorsomedial PFC has efferent connections to the amygdala: Robinson et al. 
(2012) suggested that threat relevant biases are amplified via this excitatory projection and 
that it may drive and amplify amygdala responses to threat. Dorsomedial PFC activity and 
its connectivity with the amygdala is increased in anxiety and during the anticipation of 
aversive shocks (Robinson et al., 2012). Previously Reinecke et al. (in press) also found 
increased response in the dorsomedial PFC in panic disorder compared to controls. The 
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present findings suggest, in partial support of our hypothesis, that the activity of this 
amplification circuit is reduced following a brief course of CBT. Together with the effects 
in the amygdala, these results support the hypothesis that CBT reduces an otherwise 
enhanced threat related responsivity in neural circuits known to play a role in the 
automatic detection of and response to danger cues. However, contrary to our hypothesis 
this was a general effect seen across threat picture presentation and was not restricted to 
the maintain emotion condition. This suggests that CBT can potentially increase the effects 
over and above re-appraisal training focused on this task. 
Dorsolateral PFC. Anxiety has been associated with deficient engagement of 
prefrontal cortex during the regulation of aversive cues. A number of theoretical papers 
have suggested that anxiety disorders occur when the PFC-amygdala circuit fails to 
operate successfully and the amygdala response to danger is left unattenuated (for reviews, 
see Bishop, 2007, 2008). This would be expected to lead to an over-response to danger 
cues, even when these cues were harmless, ambiguous or irrelevant.  
In a previous study on panic disorder it was found, however, that parts of this 
regulatory network, including the dorsolateral PFC, were engaged during viewing of threat, 
but that this was not sufficient to reduce amygdala responses (Reinecke et al., in press). 
Such a pattern could have occurred for a number of reasons. Firstly, enhanced engagement 
of PFC may be seen in panic disorder compared to healthy controls if a stimulus is not 
threatening enough to engage this circuitry in the healthy control group, i.e., if the threat 
does not appear to require regulation in this group but does so in the anxious group. 
Secondly, an enhanced prefrontal response may relate to the increased use of unhelpful 
safety strategies in people with panic disorder, which the healthy control group does not 
need to deploy: Hofmann et al. (2012) suggested that PFC activation was a correlate of 
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(maladaptive) cognitive avoidance of triggers that had raised limbic activation. A third 
view could be that, whilst the PFC shows increased activation in people with panic 
disorder, its connectivity with the amygdala may function insufficiently, thus functionally 
uncoupling the two.  
The present results suggest that effective CBT reduces the elevations in 
dorsolateral PFC activation in people with panic disorder, again in partial support of our 
hypothesis. This implies that the circuit is not ‘broken’ but can be used effectively if 
appropriate treatment is given. This is in line with findings that CBT can reduce activity of 
dorsolateral (Paquette et al., 2003; Straube, Glauer, Dilger, Mentzel, & Miltner, 2006) and 
ventromedial (Klumpp, Fitzgerald, & Phan, 2013; Månsson et al., 2013) PFC during 
processing of threat. The recent observation by Reinecke et al. (in press) that these 
responses can also be normalised by simply providing a single helpful reappraisal strategy 
during threat processing is in line with this interpretation. The high degree of efficacy of 
CBT in panic disorder is consistent with the observations that cognitive regulation 
strategies and learning about threat can be very helpful. As such, we may need to further 
understand the neural basis of this disorder; whether it is different from other anxiety 
disorders and how we may be able to capitalise on these effects. Again these effects were 
seen across maintain and re-appraisal blocks of aversive picture stimuli suggesting that 
CBT can still affect the processing of threat processing over and above the use of re-
appraisal strategies.  
Normal viewing versus emotional regulation. The difference in amygdala 
response during aversive picture presentation following CBT was only seen when 
participants were instructed to look at the pictures as they would naturally and were absent 
when they used reappraisal strategies that reduced their threatening nature. We also 
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observed a specific effect of CBT during maintain vs. reappraise conditions in the superior 
and middle temporal gyrus, potentially part of the extended limbic response to threatening 
cues (Leitman et al., 2008; Miyahara, Harada, Ruffman, Sadato, & Iidaka, 2013). This 
observation was outside our key hypotheses but may lend further support to the argument 
that people experiencing panic disorder can regulate limbic responses to threat when they 
have been given helpful reappraisal skills but are much less able to do so when their threat 
processing continues as normal. CBT may thus allow recipients to use more helpful 
strategies even under the ‘normal’ viewing condition. 
By contrast, the effects in the dorsomedial and dorsolateral PFC were seen 
irrespective of viewing condition (i.e., whilst maintaining affect as well as when 
reappraising) suggesting more elaborate effects of therapy which go beyond the use of 
brief reappraisal strategies. These results may suggest reduced representation of threat 
value following therapy and perhaps reduced application of unhelpful safety behaviours 
during threat processing. Again, these effects suggest that neural mechanisms of threat 
processing in panic disorder can be modulated by a psychological intervention. While 
some of these effects resemble the changes seen with pharmacotherapy, there are potential 
differences in the response of PFC circuits. In particular, SSRI treatment increased the 
response of the PFC during the processing of negative facial expressions in people with 
social phobia (Phan et al., 2013). It is of course difficult to compare results across studies, 
anxiety disorders and paradigms, but if replicated in a within-subjects randomised study, it 
may be an interesting difference, perhaps allowing better stratification of those in need or 
treatment combination in the future. 




 Since the control group in the present study was untreated, we cannot with 
certainty attribute the changes seen to the CBT per se that was offered to the treatment 
group. Nonspecific factors, such as spending time with a therapist, getting a professional’s 
attention or simply making a committed effort to try and work on one’s problem may have 
contributed to the clinical improvement seen in the treatment group, rather than the CBT 
itself. To account for such nonspecific factors and be able to relate clinical improvements 
to a specific intervention or, better, specific, ‘active ingredients’ of the intervention, a 
suitable ‘sham’ or control treatment would have needed to be offered. 
Another limitation concerns the maintain versus reappraisal task used here. 
Although reappraisal of distressing pictorial content was not practised explicitly in the 
treatment group’s CBT, changing how one thinks about triggers to distress is a core 
component of CBT. Thus the task that served as a cognitive probe in the brain scanner and 
the experimental treatment using CBT are potentially confounded. To identify such a 
possible confound the study design would ideally have included an additional control task 
less correlated with one of the group’s treatments. That said, however, the results may 
alleviate this concern somewhat because only a main effect of task, across both groups of 
participants, was obtained. 
Within the cognitive-behavioural framework panic, like other anxiety disorders, is 
conceptualised as arising from and being maintained by unhelpful, perhaps aberrant, 
cognitive processes (Clark, 1986). A debate exists whether functional neuroimaging has 
much value in helping us understand how cognitive processes operate. Some have claimed 
that functional localisation adds insufficiently to cognitive theory and our understanding of 
how the mind, whether functioning healthily or pathologically, operates (see, e.g. Coltheart, 
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2013). Others, however, have argued that functional neuroimaging does possess value 
within cognitive psychology and that it can add unique and important information to 
inform cognitive theories (Mather, Cacioppo, & Kanwisher, 2013). In a recent opinion 
paper Holmes et al. (2014) make a strong case for neuroscience within mental health 
science. They argue that neuroscience adds value, firstly, by improving our understanding 
of the mechanisms of how existing psychological interventions work, secondly by 
beginning to have the potential to optimize psychological treatments and, in the near future, 
perhaps even generating new interventions in which psychological therapy may even be 
combined with optogenetic methods to therapeutically interfere with the way the brain 
would operate otherwise. Whilst the jury between these viewpoints is still out there 
consensus is growing that neurobiological measures should not only inform our 
understanding of mental disorders but that they should even become part of a new way of 
classifying them: In 2008 the United States National Institute of Mental Health made such 
research a strategic priority (Casey et al., 2013).  
Future Directions 
The current study suggests that CBT exerts effects on the neural response to threat 
in people with panic disorder even after a brief period of application. Future studies should 
assess whether these effects can be replicated in a study using an active control condition 
which controls for nonspecific therapy effects. It would also be important to compare the 
effects of CBT to other interventions such as SSRIs to pinpoint potential for overlap or 
joint mechanisms of action. Recently interest has arisen in using pharmacological 
strategies to amplify the effects of CBT by enhancing the neural mechanisms of learning 
(Bontempo et al., 2012; Norberg et al., 2008). Neuroimaging markers may help improve 
the specificity of such combination treatments. Ultimately we may have to accept that not 
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everyone who suffers from panic disorder benefits from CBT. Studies like the present one 
may one day result in a method that helps to better predict what treatment is likely to work 
best for whom. Such information may then allow us to maximise clinical efficacy by 
matching those who are most likely to respond to a particular intervention to it and offer 
suitable alternatives to those who have been empirically shown to reap more benefits from 
those. This would not only be desirable from a treatment planning viewpoint but also help 
to deploy research funding where it is most at need, in particular to aid the discovery and 
further refinement of treatment strategies for those who can currently not benefit 
sufficiently from extant and mainstream treatment provision. 
Conclusions 
Brief CBT for panic disorder was highly effective when compared to a wait list 
control group and may be a cost effective alternative to standard interventions. CBT 
showed key effects on the neural response to threat in people with panic disorder including 
modulation of the amygdala in response to threat cues. The pattern of results suggests that 
prefrontal cortical circuits may be intact in people with panic disorder and that they can be 
used effectively when helpful cognitive strategies are trained. Without treatment these 
circuits may operate in a dysfunctional manner in panic disorder, reinforcing maladaptive 
safety strategies which prevent learning in the long term. Further studies are needed to 
compare and contrast the effects of CBT with other interventions and assess how we may 
be able to use these results to guide the application of successful therapy in the future. 
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Anxiety disorders, such as extreme shyness or s an extreme fear of suffering a 
panic attack, are very frequent and present a heavy burden not only on the sufferers but 
also on society (Baxter, Scott, Vos, & Whiteford, 2013; Kessler et al., 2006; Kessler, Chiu, 
Demler, Merikangas, & Walters, 2005; Rapaport, Clary, Fayyad, & Endicott, 2005; 
Whiteford et al., 2013). Traditionally anxiety disorders would be treated by medication but 
side effects are strong and a large number of patients tend to relapse. In recent years 
effective psychotherapeutic interventions have been developed. Cognitive behavioural 
therapy (CBT) for anxiety is now recommended as an effective alternative to medication 
(NICE, 2005a, 2005b, 2011, 2013). Nevertheless a significant number of patients respond 
insufficiently to therapy and relapse rates remain high after CBT too (Barlow, Allen, & 
Choate, 2004; Cuijpers et al., 2013; Durham et al., 2005; Roth, Fonagy, Parry, Target, & 
Woods, 2006).  
An important aspect of CBT is to teach patients to change the way they interpret 
situations that could be perceived as threatening. Specific brain mechanisms have evolved 
to enable us to detect, and respond to, danger and threat cues in our environment (Bishop, 
2007, 2008). If we were to better understand how CBT works at a brain level we may be 
able to allow us to modify components of therapy to make it even more effective. Recent 
decades have seen a surge in brain research techniques. An excellent way of studying the 
human brain is a brain scanning method called functional magnetic resonance imaging 
(fMRI; Raichle, 2009). Because it allows to identify which areas in the brain are involved 
when subjects are carrying out a specific task it is very suitable to study how the brain’s 




 Literature Review 
Chapter I of this thesis reviews the scientific literature on the neural mechanisms of 
CBT. Specifically it identified thirteen scientific studies that used fMRI to determine how 
the brain’s processing of threat changes after patients had received CBT for anxiety 
disorders. The majority of reports studied this questions in patients suffering from spider 
phobia. Three reports used patients with social phobia and two reports each studied panic 
disorder and posttraumatic stress disorder, respectively. 
All studies found that CBT was very effective in reducing patients’ symptoms of 
anxiety. They were also consistent in identifying that the brain’s threat processing network 
exhibits changes as a consequence of successful therapy. However, only little concordance 
existed across studies about which specific areas within this network are influenced by 
CBT. When studies reached agreement on some brain areas there was typically little 
consistency regarding the direction of the neural changes, i.e. whether a specific brain area 
was more or less active after CBT. 
It is encouraging that the studies identified the threat network as a target of therapy, 
since that is where CBT would most plausibly be expected to act. However, the principal 
conclusion of the review is that most studies suffered from significant methodological 
shortcomings to render their results difficult to integrate cohesively. It is early days and 
using neuroscientific principles in psychotherapy research is an evolving and promising 
field of research. 
Empirical Paper 
Chapter II of this thesis presents a brain imaging experiment carried out at the 




two halves. One received a five session course of CBT for panic disorder, after which they 
had an fMRI scan of their brains while they were presented with aversive and threatening 
pictures. The other half had no therapy initially and waited for four weeks until they had a 
brain scan using identical pictures. For ethical reasons the untreated group received 
equivalent CBT after their waiting period. During brain imaging the participants carried 
out two different tasks: for half of the time they suppressed their emotional reactions using 
mental strategies, whereas for the other half they maintained their emotional response by 
viewing the pictures as they would without applying any mental strategies to reinterpret 
their content or context.  
As expected, the volunteers who had completed their treatment experienced less 
anxiety than the control participants. Their brains showed reduced activation of areas 
involved in processing threat, particularly when they tried to maintain the emotional state 
elicited by viewing aversive pictures. 
These findings confirm the previously reported observation that a brief course of 
CBT can be a very effective intervention for panic disorder (Clark et al., 1999). It may be a 
more cost effective alternative to the standard recommendation of twelve to sixteen 
sessions of therapy (NICE, 2011). Successful symptom reduction by CBT appears to be 
related to lowered responsivity of brain areas involved in the detection and processing of 
threat-related information and in the creation and maintenance of fear. These findings may 
help with the future refinement of CBT for panic disorder, such as by supplementing a 
talking therapy with pharmacological agents that enhance patients’ ability to learn skills 
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provide the files in one of our recommended file formats with a preferred maximum size of 50 MB. Video and animation files 
supplied will be published online in the electronic version of your article in Elsevier Web products, including 
ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose any frame from the video 
or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your 
video data. For more detailed instructions please visit our video instruction pages 
at http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded in the print version of 




The journal encourages authors to create an AudioSlides presentation with their published article. AudioSlides are brief, 
webinar-style presentations that are shown next to the online article on ScienceDirect. This gives authors the opportunity to 
summarize their research in their own words and to help readers understand what the paper is about. More information and 
examples are available at http://www.elsevier.com/audioslides. Authors of this journal will automatically receive an invitation 
e-mail to create an AudioSlides presentation after acceptance of their paper. 
Supplementary data  
 
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files 
offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, 
sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article 
in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted 
material is directly usable, please provide the data in one of our recommended file formats. Authors should submit the 
material in electronic format together with the article and supply a concise and descriptive caption for each file. For more 
detailed instructions please visit our artwork instruction pages athttp://www.elsevier.com/artworkinstructions. 
3D neuroimaging  
 
You can enrich your online articles by providing 3D neuroimaging data in NIfTI format. This will be visualized for readers 
using the interactive viewer embedded within your article, and will enable them to: browse through available neuroimaging 
datasets; zoom, rotate and pan the 3D brain reconstruction; cut through the volume; change opacity and color mapping; 
switch between 3D and 2D projected views; and download the data. The viewer supports both single (.nii) and dual (.hdr 
and .img) NIfTI file formats. Recommended size of a single uncompressed dataset is 100 MB or less. Multiple datasets can 
be submitted. Each dataset will have to be zipped and uploaded to the online submission system via the '3D neuroimaging 
data' submission category. Please provide a short informative description for each dataset by filling in the 'Description' field 
when uploading a dataset. Note: all datasets will be available for downloading from the online article on ScienceDirect. If 
you have concerns about your data being downloadable, please provide a video instead. For more information 
see:http://www.elsevier.com/3DNeuroimaging. 
Submission checklist  
 
The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please 
consult this Guide for Authors for further details of any item.  
Ensure that the following items are present:  
One author has been designated as the corresponding author with contact details:  
• E-mail address  
• Full postal address  
• Phone numbers  
All necessary files have been uploaded, and contain:  
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been 'spell-checked' and 'grammar-checked'  
• References are in the correct format for this journal  
• All references mentioned in the Reference list are cited in the text, and vice versa  
• Permission has been obtained for use of copyrighted material from other sources (including the Web)  
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print, or to be 
reproduced in color on the Web (free of charge) and in black-and-white in print  
• If only color on the Web is required, black-and-white versions of the figures are also supplied for printing purposes  





Author’s own contributions to the research chapter 
This study was conceived and presented in a grant and ethics application by a 
senior postdoctoral researcher prior to my involvement with the research group. The data 
acquisition, analysis and interpretation parts of the study were going to be offered as a 
research project for a clinical psychology trainee. I was involved in the design and 
implementation of the functional imaging methods and carried out CBT in more than two 
third (19) of all study participants for a total of 95 clinical hours. The remainder of 
participants was offered CBT by team research psychologists and volunteer psychologists 
within the Lupina service, Warneford Hospital, Oxford. Clinical supervision was provided 
by a consultant clinical psychologist of the Oxford Cognitive Therapy Centre. I analysed 
the behavioural, clinical and functional neuroimaging data. I independently interpreted the 
results and authored the thesis chapter. Research supervision was provided by a senior 
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